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Summary 
 
Urinary continence depends on urine storage in the bladder until voluntarily voidance through 
a sphincter system. Any interference may lead to involuntary urine leakage bringing along 
compromised daily activities in combination with exposure to the unpleasant sensation and 
odor. To date, external urethral sphincter or rhabdosphincter (RS) physiology and anatomy 
as well as the changes during aging and tissue regeneration are not fully understood. 
Molecular biology as well as non-invasive imaging might contribute to the full understanding 
of healthy and diseased tissue and therefore may add to the development of novel 
therapeutic options and diagnostic tools. 
With two studies, we assessed muscle regeneration by multiparametric magnetic-resonance 
imaging (MRI) on a murine hind limb tibialis anterior (TA) muscle crush model, followed by an 
injection of collagen embedded human muscle precursor cells (MPCs) isolated from the 
rectus abdominis from different donors respectively of collagen only or PBS injection serving 
as control. MRI assessment of the hind limb using a 4.7T MR Scanner prior to surgery and 
on post-operatively quantified longitudinal and transverse relaxation times, and the 
magnetization-transfer ratio (MTR) as well as focusing on diffusion-tensor imaging (DTI) 
properties such as apparent diffusion coefficient (ADC) and fractional anisotropy (FA) off the 
regenerating TA muscle. Tissue specimens were histologically examined by hematoxylin-
eosin staining and immunohistochemistry. 
Neither collagen embedding of human MPCs during stem cell transplantation, nor collagen 
alone as widely applied scaffold in stem cell research did influence the retrieved MRI 
parameters delineating muscle regeneration of the TA with increasing longitudinal and 
transverse relaxation times as well as decreasing MTR. Injected haSSCs form de novo 
muscle tissue in situ following a defined pattern in DTI-MRI highlighting the direction of the 
newly formed fibers. Histological examination proved that all study groups concluded TA 
regeneration, suggesting that murine MPCs cells contributed significantly to the muscle 
restoration. Our results show, that this murine TA crush model, ideally with radiation depleted 
satellite cells, does lend itself for advancing MR methodology for monitoring of stem cell 
therapy as possible treatment for SUI. These results can easily be transferred to the clinical 
setting as a non-invasive biomarker for the assessment of muscle tissue regeneration in 
patients. 
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Urinary continence depends on urinary storage and voluntary voiding through a sphincter 
system. Any interference may lead to involuntary urinary leakage bringing along 
compromised daily activities in combination with exposure to the unpleasant sensation and 
odor. Conservatively evaluated, urinary incontinence (UI) affects approximately 20% all of 
women and may be as high as 50%1–3 causing an estimated annual health care cost of $82.6 
billion by 2020 just for the United States. These economic burdens on society and individual 
patients will increase with the rapidly aging societies4. 
To date, external urethral sphincter or rhabdosphincter (RS) physiology and anatomy as well 
as the changes during aging and tissue regeneration are not fully understood. Molecular 
biology as well as non-invasive imaging might contribute to the full understanding of healthy 
and diseased tissue and therefore may add to the development of novel therapeutic options 
and diagnostic tools. 
1.1 Anatomy and physiology 
Continence is achieved by a complex interplay of the internal and external urethral sphincter, 
bladder neck, urethral smooth muscle, pelvic floor, efferent and afferent nerves, vascular 
plexus and the surrounding connective tissue. Thereby, the human RS prevents involuntary 
urine release by providing both resting urethral tonus via slow-twitch fibers and rapid 
refractory contraction as the abdominal pressure rises. The bladder function is under control 
of the autonomic (sympathic and parasympathic) and somatic nervous system. The 
autonomic as well as the somatic nerves hold afferent (sensory) and efferent (motor) 
functions5. The neural component is controlled by cephalic control centers, spinal cord nuclei 
and infraspinal relay stations and peripheral ganglia terminating as intricate neuroplexuses 
within the vesicourethral muscle6,7. The act of micturition consists of filling, storage and 
voiding phases, which involve inverse functions of the bladder smooth muscle (detrusor) and 
the urethra (vesicourethral muscle)6: Detrusor relaxation allows urine storage, whereas the 
contraction leads to urine expel into the urethra8; while, the external an internal urethral 
sphincter relax. 
It is still under discussion, whether a progressive, age-dependent decrease of striated 
muscle cell density followed by continuous loss of striated muscle cells leads to urinary 
incontinence mediated through apoptosis9 or whether a compromised nervous control of RS 
function is the main cause10 unless physical rupture of the tissue is given. Most common risk 
factors for female stress urinary incontinence (SUI) are aging, obesity, as well as pregnancy 
and child birth11. Especially the physical damage during vaginal birth,may lead to decreased 
urethral closure pressure due to damage to the pelvic nerves followed by delayed conduction 
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in the pudendal nerve or denervation of the pelvic musculature12. Whereas type 2 diabetes 
as well as smoking cause UI is still under discussion13.  
1.1.1 Rhabdosphincter 
The human RS is sexually dimorphisitc: the male RS encircles the urethra forming a loop of 
continuous muscle bundles running along the anterior and lateral aspects of the prostate 
extending cranially to the bladder neck in a omega-like shape14 whereas the female RS is 
semicircular15 surrounding the middle third of the urethra and is located within the pelvic 
cavity in the urogenital hiatus of the pelvic diaphragm, and in the perineum16. RS is a striated 
and therefore under voluntary control. It surrounds the smooth muscle of the urethra17 and 
contains both slow and fast-twitch fibers. Thereby type 1 muscle fibers are predominant over 
type 2 muscle fibers where 2A (fast fatigue resistant) fibers are more prevalent than 2B fibers 
(fast fatigable)18. Smooth muscle fibers may interlace the skeletal muscle fibers16. Abundant 
connective tissue and numerous intramuscular nerves without spindles indicate the capacity 
to produce sustained contractions and to react to stress19. 
Skeletal muscle, is composed of longitudinally aligned cylindrical, multinucleated bundles, so 
called myofibers, arrayed within sheaths of connective tissue and extracellular matrix (ECM) 
20. The endomysium surrounding single myofibers; the perimysium around muscle bundles 
and epimysium covering the entire tissue21. Main skeletal muscle functions are movement, 
heat production and energy storage as well as protection of inner organs from physical 
trauma. Function-specific physiological and biochemical tissue variances control contraction 
speed, fatigue-resistance and metabolism, mainly through myosin heavy chain isoforms: type 
I (oxidative slow-twitch), IIA (oxidative fast-twitch), and type IIB (glycolytic fast-twitch); Types 
IIA / B are the rodent equivalent to human type IIX (glycolytic fast-twitch). In concerns of 
contraction speed, type I is the slowest, followed by type IIA and IIX/B the fastest18. During 
micturition fiber elasticity and contraction force is reduced for both type I and IIA fibers22. 
Age-related changes in RS anatomy show pathophysiological implications due to decreased 
urethral support similar to changes in levator ani defects23. Different hormonal backgrounds 
lead to gender-specific fiber architecture and quantity of elastic fibers of the endopelvic 
fascia. The male endopelvic fascia is multilayered and contains abundant smooth muscle 
fibers, whereas the female endopelvic fascia is solid, thick, and contains abundant elastic 
fibers rather than smooth muscle24. 
While little tissue turnover occurs under homeostatic conditions in vivo, muscle fibers 
undergo physiological changes (atrophy, hypertrophy, or fiber type switch) when exposed to 
excessive physical stress, such as tearing or blunt trauma. Generally, skeletal muscle is able 
to regenerate from damage to the sarcolemma or myofibrils inflicted by muscle contraction 
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without inducing an inflammatory response, thus preserving morphological and functional 
features25,26. On contrary, volumetric muscle loss, causes destruction of whole muscle fibrils, 
fibers or entire muscle segments leading to hypercontraction and followed by muscles loss 
due to necrosis, apoptosis or autophagy making lager injuries non-reversible as they are 
often replaced by non-functional fibrotic tissue27. Muscle regeneration after injury and 
necrosis can be separated into three tightly timed phases. Within minutes after the injury, 
acute inflammation is initiated, lasting for up to 14 days during which invading granulocytes 
and macrophages secrete chemokines, cytokines, growth factors and potentially damaging 
cell substrates, such as NO, reactive oxygen species and proteases, therewhile initiating 
regeneration28–30. In parallel, injury-related destruction of the dense vascular network 
normally supplying the tissue with oxygen and nutrients whilst discarding metabolites direct 
crosstalk between satellite stem cells (SSC) and the endothelium, ensures a proper 
coordination of angiogenesis and myogenesis during regeneration25,31,32. During this phase 
angiogenic capillary sprouts invade the damaged muscle tissue to vascularize newly formed 
myofibers and support their growth orchestrated by activated SSCs (aSSC) and newly 
emerging myofibers themselves as well as endothelial cells that provide growth factors33,34, 
chemokines35 as well as cytokines36 while pericytes surround the endothelial cells to stabilize 
forming neo-vasculature25. Vascular endothelial growth factor (VEGF), one of the major 
factors of angiogenesis32, which is produced by a variety of cell types is up-regulated during 
hypoxia in the regenerating muscle and drives endothelial cell chemotaxis, differentiation, 
proliferation as well as survival. Resident quiescent SSCs (qSSC)37, located between the 
sarcolemma and the basal membrane of muscle fibers38,39 thereby play a regulatory role in 
the differentiation of committed SSCs and promote their proliferation and myogenic 
commitment after activation. The differences in the qSSC commitment are controlled by 
SSCs and niche factors. Responsible for the maintenance of SSC commitment diversity is 
the orientation of the cell division plane in the SSC niche, e.g. between basal lamina of the 
muscle fibers and sarcolemma. Planar diffusion herbeby generates two daughter qSSCs, 
while apical division gives rise to a qSSC and, in case of the daughter cell losing contact with 
the basal lamina, aSSC25,40,41. This process is tightly regulated by the Notch signaling 
pathway42 and is important for the maintenance of SSC self-renewal as the lack of Notch 
signaling leads to myogenic commitment of the SSCs and their transformation into 
myoblasts. The activation of SSCs can be induced intrinsically43 or by extrinsic signals, such 
as muscle injury, leading to the initiation of myogenesis. The activation and subsequent 
myogenic differentiation of qSSCs is controlled by myogenic regulatory factors (MRFs), such 
as MYF5, MyoD, myogenin and MRF4. Upon activation, committed SSCs start expressing 
markers of myogenic commitment, followed by cell migration out of the sub-laminar niche 
and their differentiation into the fast proliferating myoblasts44. After reaching terminal 
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differentiation, myoblasts withdraw from the cell cycle, elongate and start expressing myosin 
heavy chain and α-actin. These terminally differentiated myocytes fuse to multinucleated 
myotubes, further aligning to myofibers and finally forming mature skeletal muscle45. 
Muscle regeneration can be impaired by tissue microenvironment changes, such as chronic 
inflammation, fibrosis or ageing40,46 causing a loss of qSSC leading to disturbed self-renewal 
or loss of tissue homeostasis in response to injury. However, little is known about tissue 
repair and inflammatory processes in specialized skeletal muscle tissue, such as the RS. 
Further research performing proteomics and substantial quantification during regeneration 
using RS biopsies from cystectomy patients or animal models simulating childbirth injuries 
via vaginal distension (VD), pudendal nerve injuries, anatomic support damage of the pelvic 
floor including urethrolysis, pubourehtral ligament damage, intraurethral damage such as 
sphincterectomy or pudendal nerve transaction47 may help to understand the tissue-specific 
physiology in future.  
1.1.2 Extracellular matrix 
The endopelvic fascia and other connective tissue elements of the pelvic floor are at risk of 
stretch and detachment after childbirth. During pregnancy, the pelvic floor undergoes 
hormone-mediated physiological changes in its biomechanical properties, resulting in an 
increased distensiblity of the vagina. Animal models have shown that the vaginal wall and its 
supportive tissue complex is more distensible and less stiff during pregnancy48. This process 
is mediated by increased synthesis of collagen and elastin by fibroblasts. Collagen and 
elastin are two main components of the extracellular matrix of the connective tissue. 
Collagen determines the tensile strength while elastin contributes to the tissues’ stretch 
ability. Collagen is the major structural component contributing to 1-10% of the tissue dry 
weight. Type I and fibrillar types I and III collagens are predominate in adult endo-, peri-, and 
epimysium20. Fibroblasts, sensitive to mechanical stretch, adapt connective tissue synthesis 
proportional to the degree of stretch. 
Connective tissue remodeling after vaginal delivery is mediated via the upregulation of ECM 
genes, such as elafin (a elastase-specific protease inhibitor), keratin 16, collagen type XVII, 
plakophilin 1 (a desmosome-related protein)in vaginal tissue of women with stress urinary 
incontinence49. These changes in collagen and elastin synthesis and degradation influence 
tissue stiffness. However, it is yet unanswered, whether these changes are the cause or the 
result of SUI48 and must be investigated with specific gene knockout animal model. 
Excessive stretching of the vaginal wall initiates a degradative response mediated by release 
of collagenases from activated fibroblasts. This results in increased degradation of collagen, 
as well as other constituents of the vaginal wall. Thus, difficult or prolonged labor may 
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exceed the stretch limits of the soft tissue, causing imbalance in the reparative and 
degradative processes and increasing susceptibility of pelvic floor supportive structures to 
birth trauma50. Allover, the content and spatial organization of collagen subtypes are the key 
factors of tissue strength and elasticity and therefore, collagen synthesis and metabolism 
likely has a effect on tissue functionality, micturition control and continence51. Besides giving 
organizational support to the skeletal muscle architecture, the ECM plays an important 
biomechanicistic role participating in the signaling cascade connecting the neuromuscular 
junctions52 and protecting remaining muscle mass after overload injury via increased 
mechanical stability53. Despite the many biological adaptions to vaginal childbirth including 
muscle fiber elongation, increased collagen synthesis in the intramuscular ECM54 and 
changes in pelvic floor muscle tissue stiffness due to glycosylated crosslink changes55, the 
pelvic floor tissue is prone to injury as delivery-related mechanical strains cause acute 
sarcomere elongation56. Women with SUI have lower endopelvic collagen content57. 
Collagen is cleaved  extracellularly from pro-collagen precursor molecules58. It is under 
discussion whether lower collagen levels in SUI arise from increased degradation, decreased 
biosynthesis, or both. Whilst Rechenberger et al. suggest lower collagen content due to a 
decrease in collagen biosynthesis57, Chen et. al. indicate that lower collagen content in the 
endopelvic fascia and skin of women with SUI is not due to changes in collagen synthesis58 
and Kushner et al. suggest increased collagenolytic activity compared to healthy controls59. 
Periurethral vaginal tissues from incontinent women expresses less tissue inhibitors of 
metalloproteinase (TIMPs) compared to healthy tissue whereas active metalloproteinases 
(MMPs) are expressed similarly. Interestingly the TIMP expression from fibroblasts correlates 
with estradiol levels whereas MMP expression is not altered by estradiol levels60. As ECM 
metabolism is modulated by reproductive hormones61–63 the phase of menstrual cycle in 
which biological specimens are collected is of crucial importance to be able to differentiate 
between hormonal and disease-derived alterations64 which may explain the different findings 
on collagen expression and turnover: Lower gene expression of fibrillin-1 in SUI whereas no 
significant changes for collagen I, collagen III, fibromodulin and fibulin-5 occurred65. 
Comparison of rat urethral striated muscle and ECM morphological characteristics has 
shown that mild diabetes mellitus and pregnancy can lead to a time-dependent disorder and 
tissue remodeling compared to virgin animals66 seen by the increase in total collagen area, 
fibrosis and loss of total fiber number and fast twitch fibers amongst other morphological 
changes. Chen et al. reported, that the balance between MMPs and TIMPs defining collagen 
turnover  is in favour of protein expression in the vaginal wall of SUI and pelvic prolapse 
patients67. Urinary proteomics in female SUI patients revealed an overexpression of plasma 
serine protease inhibitor, leucine-rich alpha-2-glycoprotein, lysosomal alpha-glucosidase, 
and peptidyl-prolyl-cis-trans isomerase A, and lower expression of uromodulin, which forms 
Rhabdosphincter: The key element in stress urinary incontinence 
Anatomy and physiology 
7 
 
forms high-molecular weight filaments that constitute the matrix of hyaline casts68, and 
TALPID3, a regulator of centrosome and cell polarity69 as well as collagen I (strength), III 
(elasticity) and V (function unknown), which are cleaved by MMP-1,8-13 (interstitial collagen / 
type I and III) and MMP-2 and 9 which degrade elastin and cleaved collagen into amino 
acids46. Analysis of vaginal wall tissue from SUI patients compared to menstrual-cycle 
matched withc continent women shows changes in decorin, fibromodulin an biglycan. In 
addtion para-urethral ECM proteoglycans binding to collagen and growth factors, further play 
a crucial role in cell proliferation, migration and adhesion and tissue elasticity, in a hormonal 
and continence dependent manner70. Protein and gene expression analysis support the 
nerve-mediated pelvic tissue degeneration as a cause of SUI development as 
neurodegeneration-linked proteins APOE, GRB2, and GBA are upregulated in post-
menstrual SUI patients compared to continent women64. Collagen synthesis in endopelvic 
fascia is not altered in female stress urinary incontinence58 while collagen marker levels in 
women with SUI suggest a reduced collagen turnover51. Cohort analysis of primiparous 
female rats with experimentally induced SUI showed an increase of Smad2, mmp13 and 
smooth muscle inhibitor Rgs2 in the incontinent rats further highlighting the roles of 
inflammation, collagen breakdown, and smooth muscle inhibition as important factors in SUI 
development71. Moreover, the expression of elastin and lysyl oxidase family genes in murine 
urogenital tissues of decreases with aging72. 
1.1.3 Innervation and functionality 
Skeletal muscle contraction is known to be controlled by a calcium-dependent structural 
change in the actin-containing thin filaments. The action potential in a motor nerve that 
triggers an action potential in a muscle cell membrane at the neuromuscular junction leads to 
an intracellular calcium concentration increase: calcium binds to troponin in the actin-
containing thin filaments and the resulting structural changes in the thin filament allow 
myosin motors from the thick filaments to bind to actin and generate muscle contraction73,74. 
Deficient RS activity may be of neurological or non-neurological origin75. During muscle 
regeneration, re-innervation of the damaged tissue begins from the surrounding healthy 
tissue and directly defines the type of myofibers to emerge during the tissue regeneration, 
e.g. either slow- or fast-twitch fibers76. Motor neurons control the contraction of skeletal 
muscle via neuromuscular junctions (NMJ) and neurotransmitter release, such as 
acetylcholine37. Furthermore, motor neurons are responsible for growth factor production, 
especially via the NMJ that are capable of governing the behavior of SSCs in their activation 
and proliferation77. Motor axons in peripheral nerves have the capacity to regenerate after 
injury, but fully functional motor recovery rarely occurs in clinics. Recent findings suggest a 
critical time window of 1 month after injury in which full neuronal functionality may be 
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restored78. Electrical stimulation, exercise or their combination may enhance peripheral nerve 
regeneration after injury79,80. The urethral pressure as defined by the International 
Continence Society as the fluid pressure needed to just open a closed urethra81 and hence, 
the urethral pressure profile (UPP) indicates RS activity. In SUI, the lower pressure required 
for urine outflow is an indicator for unvoluntary leakages. Both passive urethral pressure 
profile measures as well as the valsalva leak point pressures correlate with some severity 
measures of stress incontinence82. Another method to assess the functionality and therefore 
the innervation of the RS is video-urodynamics, wherein filling and voiding of the bladder is 
measured. However, even when performed under "good urodynamic practice", urodynamics 
is prone to false positve results showin pathological findings in symptom-free healths 
subjects83. RS electromyography (EMG) of the striated urethral sphincter permits detection of 
individual motor unit action potentials and is a valuable diagnostic tool in the evaluation of 
voiding disorders84. The EMG of the pelvic floor to assess RS neurophiosology can either be 
performed using patch electrodes but also EMG of the rhabdosphincter using needle 
electrodes. Whilst the urinary bladder and urethra are innervated by all three neural systems 
– sympathetic, parasympathetic and somatic – the RS is under control of the somatic 
nervous system. The pudendal nerve is a mixed nerve composed of sensory, motor, and 
autonomic fibers85. After the release of norephidrine, a excitatory α-adrenergic response 
leads to an increase in muscular tonus, whereby the bladder outflow is inhibited86. In 
humans, the RS gets its input through somatic and autonomic pathways. Besides voluntary 
control, there is evidence of a sympathetic reflex whereby bladder stretching results in the 
stimulation of β-adrenergic receptors in the detrusor that enhance bladder relaxation and 
inhibit parasympathetic activity. The question, whether this bilateral innervations is crucial for 
proper functioning remains unclear to date. Originating from the Onuf nucleus in the sacral 
spinal cord from the S2–S4 nerve roots via the pudendal nerve, signal transduction in men 
follows nerve of the penis after it splits from the pudendal nerve87,88. In the female RS, the 
intrapelvic somatic fibers along the anterior vaginal wall supply the pelvic floor89]. The 
urethral muscles receive somatic information from the pudendal nerve entering from the 
perineum. Dual somatic innervation of the RS is suggested as are branches from the 
perineal nerve and an intrapelvic component that course nearby to the pelvic nerve90 so that 
the afferent nerve fibers from the proximal urethra mainly pass through the pelvic plexus, 
whereas the afferent innervation of the distal urethra is provided by the pudendal nerve91. 
In both females and males, the striated muscle tissue is intervened by the vagina and 
prostate, respectively92. To date, the precise innervation of the RS in either sex remains 
particularly unclear. However, it is well confirmed that the internal urinary sphincter (smooth 
muscle tissue) and the RS get dual response from the pelvic and pudendal nerve. 
Descriptive anatomical studies on the male RS shows innervation via axons from the pelvic 
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nerve and dual innervation from an intrapelvic branch and a perineal branch of the pudendal 
nerve92,93. Large axon bundles surrounded by perineurium have been detected within the RS. 
These bundles are themselves encircled by Schwann cells, contain between 1 and 3 axons 
forming autonomic adrenergic nerve ends and surface junctions with the striated muscle of 
the RS94.  
Pudendal nerve transections (PNT) decrease contraction amplitude and voided volume, and 
increase in contraction duration and residual volume95. Pudendal nerve is particularly 
vulnerable to injury during VD96. Compression and stretching, damage to the fascia, 
ligaments and pelvic floor muscles during childbirth are a result of neuropathic changes. As a 
result levator ani muscle may fail to reflexively contract and elevate sphincter pressure during 
a cough or sneeze97. PNT unlike VD shows no recovery of leak-point pressure (LPP) 
whereas striated muscle tissue does not alter significantly98. In females suffering from urinary 
retention, which contrary to SUI is described as voiding difficulty, urethral closure pressure 
and urethral sphincter volume are increased99. Histopathological examination of women with 
SUI in combination with pelvic floor prolapse revealed an increased density of collagen, 
decreased hexosaminidase activity without changes in glycosaminoglycans100. However, to 
date it is not possible to argue that a change in collagen structure or quantity by itself cause 
SUI.  
1.2 Therapeutic options 
Currently rehabilitation of skeletal muscle function includes vaginal pressaries101 physical, 
pharmaceutical or interventional treatment options102,103. However, these methods show 
tremendous patient-to-patient variability and only limited success. Whilst interventional 
attempts relying on synthetic materials have been heavily condemned due to severe 
complications and limited success. The field of tissue engineering (TE) combining materials 
science, chemistry, biology and medicine104–108 in order to develop tissue-like structures109 in 
vitro with the aim to implant these constructs into the body to repair an injury or replace the 
function of a failing organ may solve the problem. 
Conservative treatment options for SUI includes injectable or implantable bulking agents 
(e.g.110,111) or sling surgery but risk of reoperation is common112,113 and certain materials such 
as Mersilene may cause a chronic inflammatory response114 of the surrounding tissue 
showing an increased risk of rejection.  
Pelvic floor muscle exercise or physiotherapy is a preferred frontline therapy as it 
strengthens the pelvic floor muscle and improves RS efficiency non-invasively115 either 
through voluntary contractions116, vaginal weight cones117 or electromagnetic stimulation118. 
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Exercise can reduce severity of SUI symptoms in conceiving women119. However, the 
variances between the applied exercise protocols complicate comparisons. Success 
therefore may be enhanced through telephone calls or feedback of exercising 
effectiveness120. Animal studies suggest that immediate electromagnetic stimulation after 
denervation leads to more effective recovery than delayed application121. In case of VD, this 
would suggest that immediate post-delivery intervention might prevent neurodegeneration. 
However, this assumption must be tested in a clinical environment.  
1.2.1 Tissue Engineering and cell therapy 
The overall goal of TE is to incorporate the bioengineered tissue into the surrounding tissue 
to form a functional unit and result in a final, purely biological substitute to re-establish tissue 
function4,104,105. For instance, injection of autologous cartilage cells as bulking agents into the 
bladder neck and trigone region to correct anatomical deformities has been performed 
successfully in patients with urinary incontinence106 and vesicoureteral reflux107. Notexin 
injection into the female rat RS and subsequent analysis of cells, has shown that satellite 
cells within the RS contribute to tissue regeneration in the same manner as in other skeletal 
muscle tissue122.  
The majority of SSCs are committed to the myogenic lineage123 and are therefore most 
suitable for muscle bioengineering. These cells can be isolated from muscle biopsies, grown 
in culture and re-implanted into an injured or weakened muscle, where they lead to structural 
reconstruction and improve contractile function124,125. SSCs can be isolated from patients of 
all ages and both sexes, forming new muscle tissue in a time-dependent manner126. 
Depending on the patterns of cell division in stem cell lineages, a mother cell can divide into 
two cells of the same fate (symmetric division) or to two daughter cells of separate fate 
(asymmetric division)127. In contrary to embryonic stem cell (ESC) or induced pluripotent 
stem cells (ipSC), for adult stem cells there is no tumorogenicy documented and compared 
to ESC no ethical concerns exist128,129.  
Besides finding a suitable cell source, appropriate scaffolds for the extracellular environment 
is required. The scaffold should serve as a temporary structure that will degrade or resorb 
and become replaced by the host109. Tissue scaffolds typically purposes on or several of the 
following characteristics providing a surface for cell attachment or migration, an assembly of 
biochemical factors enhancing growth, innervation or cell guidance; porosity enabling 
diffusion of nutrients and stability mimicking the critical aspects of the in vivo setting130. 
aSSCs treatment has the potential to become the first treatment to restore RS muscle 
function123,131,132 by mimicking the tissue response upon injury. Animal studies have 
demonstrated the applicability of cell therapy for the treatment of SUI and other acquired 
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myopathies131–136 and ongoing clinical trials are trying to confirm these results for patient 
application using both muscle137–144 and adipose145–148 tissue- derived stem cells in women 
and men. Clinical trials with UI patients, using autologous cells showed no signs of rejection 
or other side effects so far, proving that the application of for skeletal muscle regeneration is 
feasible, safe and ready for the “bench to bedside” transfer. A comparison of male RS 
muscle cells and other skeletal muscle tissue has shown high degree of similarity in 
membrane properties149. 
The proof of long term sphincter restoration or even the replenishment of the stem cell pool; 
that tissue homeostasis and response to recurring tissue damage and acute inflammation will 
be guaranteed, is still undescribed. Moreover, it still is under debate, whether improved 
continence after cell therapy is due to functional differentiation of injected stem cells or 
whether a systemic cytokine-controlled effects triggers the regeneration of the RS150: Besides 
improved continence measured after injection of stem cells139,140,143,151 homing of stem cells 
after perineal application or directly due to injury-related signaling factors has been 
emphasized. The combination of physical therapy, such as by electrical stimulation, might 
enhance the outcome of cell therapy due to upregulation of the cytokines CXCL12 and CCL7 
resulting in an increase of muscle regeneration in a model of a chronic large anal sphincter 
injury152. To ensure muscle functionality and to obtain complete muscle regeneration, muscle 
tissue has to be properly re-innervated after damage as lack of innervation leads to 
progressive muscle atrophy. It has been shown that myoblast differentiation and subsequent 
fusion into myotubes occurs faster when the neuronal network controlling muscle contraction 
is undamaged compared to non-functional motor neurons153. 
1.3 Imaging 
The best spatial resolution and contrast to image cells in a biological environment is provided 
microscopy imaging. However, most such methods require a post-biopsy processed tissue 
sample and therefore are invasive. Furthermore current microcopy technology is limited by 
tissue penetration depth below millimeter-range. The few devices available for clinics focus 
on imaging of ectopic easy accessible tissues such as skin, cornea or retina. Hence, access 
to both healthy and diseased tissue via cadavers154 or suitable animal models are needed to 
overcome this issue. However, for the comparison of human tissue with animal models, 
normalization tools such as architectural difference indexes parameterizing a combined 
measure are required. Parameters such as sarcomere-length-to-optimal-sarcomere ratio, 
fiber-to-muscle-length ratio, and fraction of total pelvic floor muscle mass and physiological 
cross-sectional area are used full tools155 besides standardized termiology, testing 
procedures and well matched diagnostic instruments156. Alternatively, non-invasive imaging 
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may be used. However, X-ray and computed tomography (CT), because of low sotft tissue 
contrast, as well as positron emission tomography (PET) and single-photon emission 
computed tomography (SPECT) due to radioligand accumulation in the urinary bladder, are 
unsuitable despite the general potential to asses skeletal muscle physiology such as insulin 
sensitivity, VO2 max
157 or glucose metabolism158 but also cell tracking159–162 and viability163 
detection after myoblast transfer therapy(MTT). In comparison, modern magnetic resonance 
imaging (MRI) and ultrasound (US) scanner technology, allow the tracking of cells in clusters 
allowing the imaging of unlabeled single cells and small cell aggregates164 or the study of 
ECM and describe the tissue anatomy. 
T1, T2 weighted as well as dynamic MRI allow to post-operatively asses the position of the 
slings, but contrast is dependent on the sling material165,166 or bulking agents and allow the 
assessment of structural changes167 as well as the visualization of pelvic floor anatomy 
through multiplanar localizer, axial and coronal T2 fast spin echo (FSE)168 or damage after 
childbirth and allows an association with SUI169,170. Using T2-weighted MRI of the urethra and 
the surrounding ligaments as example, we are able to distinguish whether SUI in any given 
patient is due failure of the supporting tissue or sphincter deficiency171. Diffusion-weighteed 
MRI (DW-MRI) with the thereon computed apparent diffusion coefficient (ADC) maps may 
allow the detection of ischemia and may be used to identify edemas after surgical 
intervention. Anatomical findings by MRI or neurophysiological findings by EMG indicate, a 
connection of RS shortening and poorer pelvic floor muscle function such as shorter 
amplitude, duration of motor unit action potentials (MUP) with decreased turns and worse 
MUP recruitment during bladder filling23,172,173. Intravaginal EMG (partially in combination with 
endorectal probes) has enabled the mapping of the innervation zones of the pelvic floor and 
RS muscles174. MR neurography sequences applied to fresh cadaver specimen before and 
after surgical marking of different nerve segments could easily detect the proximal pudendal 
nerve. However, MR pudendal nerve neurography is prone to poor spatial resolution and 
signal to noise ratio on wide field-of-view imaging, inhomogeneous fat suppression, nerve 
branching variations, and surrounding vessels, especially in the setting of pelvis venous 
congestion85 but still can be interpreted by experienced radiologist175. Van der Jagt et. al. 
have shown feasibility of diffusion tensor imaging (DTI) and fiber tractography to study the 
nerves of the sacral plexus in humans in vivo and to assess the architectural configuration 
and microstructural properties of these peripheral nerves including the pudendal nerve176. 
MR angiography, such as time-of-flight, phase-contrast, or contrast-enhanced methods, such 
as susceptibility weighted imaging or blood-oxygen-level dependent functional MRI have not 
been tested for RS imaging to date.  
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Imaging after cell therapy is the most demanding, as not only the anatomical restoration is of 
interest, but also the fate of the cells or the implant. Magnetizaiton Tranfer imaging (MT) has 
been demonstrated to be of value for a variety of applications including the evaluation of 
skeletal muscle pathologies177 muscle damage and repair over time upon myotoxin injection 
in the mouse hind leg178 and can be used to follow-up differentiation of injected muscle 
precursor cells179 as a biomarker of the quantity and quality of muscle fiber formation179. 
Furthermore, superparamagnetic iron oxide nanoparticles, can be used track muscle 
regeneration after cell therapy without negative effects on the functionality of the 
bioengineered muscle180 while applications of DWI and DTI represent promising tools to 
monitor including the muscle181–184 visualization of variations in diffusion reveals tissue 
microstructure and its architectural organization, which allows following fiber-tract trajectories 
in fibrous tissues185. MR imaging relaxation and diffusion measurements can be used as 
potential biomarkers for non-invasive in vivo monitoring of the myogenic differentiation 
process from muscle precursor cells to mature skeletal muscle tissue in muscle cell 
therapy186. Age-related changes in tissue composition can be shown via high-resolution MR 
spectroscopy (MRS) as demonstrated in mice187 but to date, there is no data available on MR 
spectrcopic studies for the RS metabolism. Whilst tissue stiffness has been documented for 
various skeletal muscle tissue188, the pelvic floor has not been analyzed to date, elastin 
specific MR contrast agents (ESMA)189,190, DW-MRI and dynamic contrast-enhanced MRI 
(DCE-MRI)191 might upbring new insights. 
Transurethral US enables the visualization the anatomical arrangement and contractions of 
the RS loop, scar formation for patients with postoperative SUI14. Intraurethral US allows 
clear visualization of voluntary contractions and RS configuration during micturition including 
measurement of RS thickness and estimate the grade of fibrosis and lipomatosis192,193. 
Overall, US corresponds to urodynamic parameters giving rise to new diagnostic tools194 as it 
has shown that primi- and multipara have decreased numbers of elastic fibers compared to 
nullipara, most probably as an effect from severe tissue damage after childbirth in 
combination with impaired regeneration195. Data about vascularization of the RS and the 
surrounding tissue has been obtained from the use of US contrast agents and intraurethral 
US devices allowing the estimation of blood volume and flow196. Furthermore, Doppler US 
enables visualizing the urethral vasculature involved in the mechanism of urethral closure197. 
Thereby it could be shown that compared to continent nullipara, continent multipara have a 
significant reduction in vascularity198. Siracusano et al. showed blood volume and blood flow 
decreased with age but no changes in velocity in pre- and postmenopausal women after 
contrast-agent enhanced US196. In future, elastography either using US or MRI might be 
established for the pelvic floor and help to give information on tissue inﬂammation, and 
ﬁbrosis as well as changes in stiffness of tissue by assessing the propagation of mechanical 
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waves through the tissue with a special magnetic resonance imaging technique. In case of 
US199 and MR elastography shear waves generated within the tissue are acquired via MRI 
and post-processed to generate quantitative maps of tissue stiffness, the so called 
elastograms200. Shear wave US elastography201 may give further insights into, ECM changes 
and measurement of tissue elasticity with reflecting collagen contents202. This may be 
supported with elastin-specific MR contrast agents203 or endoruethral sonography similarly 
performed as endoanal US204. Considering the emerging role of the pelvic floor ECM in SUI, 
imaging the mechanical properties of the tissue surrounding the RS may be important to 
track the disease progression, recognize indications of disease development and monitor the 
progression of recovery. 
1.4 Outlook 
Besides conservative approaches, several clinical trials on myoblast transfer therapy (e.g. 
138,140) in order to overcome SUI have been performed during the last decade or are currently 
being performed currently. These studies focus surgical attempts using novel slings, 
pharmaceuticals, physiotherapy or cell therapy. According to clinicaltrials.gov currently 
arround 70 studies are ongoing or rectruiting patients for various therapeutics inverventions. 
However, the outcome of these trials is difficult to compare due to small cohort size, short 
evaluation periods or different cell sources (muscle-derived stem cells, adipose tissue-
derived stem cells, cord blood stem cells or total nucleated cells) and number of injected 
cells 205. Furthermore all those clinical studies have different parameters to evaluate the 
outcome of their trial. Hence, it is important to introduce a standard evaluation systems 
followed strictly by all clinical trials and basic research projects focusing on SUI. 
1.5 Conclusions 
The RS is the key element in SUI which affects the lives of millions of people worldwide and 
imposes a substantial economic burden on every health care system. It is still unclear which 
is the key factor causing RS deficiency as innervation, stem cell senesence as well as the 
ECM contribtue to healthy tissue homeostasis and are altered in disease state such as SUI. 
Due to the high impact on tissue functionality, neither genomics, transcriptomic, proteomic or 
metabolic data is available for healthy and injured RS at any age class, sex or type of 
functionality loss and hinder detailed research to date. Besides getting tissue samples en 
passant of cystectomy or prostatectomy, non-invasive imaging could support the 
understanding of disease development and the processes of subsequent therapy. 
Therapeutics interventions vary from surgical applications of slings supporting the pelvic floor 
structures, pharmaceuticals physioherapy and tissue engineering approaches. However, due 
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to no standarisation in the evaluation of the trials, it is difficult to compare the success of 
these studies. 
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2.1 Abstract  
Purpose: In this study, we show that the measurement of tissue water diffusion properties 
using magnetic resonance imaging (MRI) enables the monitoring of skeletal muscle tissue 
regeneration after injection of human activated satellite stem cells (haSSC) in an athymic 
mouse model. 
Methods: haSSCs were isolated, characterized and expanded before injection into a 
crushed mouse tibialis anterior muscle. In situ differentiation was followed up via MRI (4.7 T 
scanner) for 21 days by focusing on diffusion-tensor imaging (DTI) properties such as 
apparent diffusion coefficient (ADC) and fractional anisotropy (FA) of the de novo tissue. The 
results were confirmed by histology and immunohistochemistry. 
Results: Mice treated with haSSCs showed similar regeneration as mice treated with 
collagen or PBS. DTI revealed that de novo generated muscle fibers were orientated in the 
same direction as the fibers in the surrounding healthy tissue that were not affected by the 
initial muscle crush injury. An increase in muscle specific markers confirmed cell 
differentiation and myofiber formation. In all study cohorts, similar patterns for diffusion 
values were observed. The ADC (10-3 mm2/s) increased in all groups, reaching its maximum 
on post-operative day (POD) 1 (haSSCs 1.47 ± 0.12, PBS 1.48 ± 0.09, collagen 1.40 ± 0.11); 
FA reached minimum values on POD 1 (haSSCs 0.17 ± 0.04, PBS 0.16 ± 0.03, collagen 0.19 
± 0.05), approximating baseline values thereafter. 
Conclusions: Injected haSSCs form de novo muscle tissue in situ following a defined 
pattern in DTI-MRI highlighting the direction of the newly formed fibers. These results can 
easily be transferred to the clinical setting as a non-invasive biomarker for the assessment of 
muscle tissue regeneration in patients. 
Keywords: human activated satellite stem cell (haSSC) ■ myoblast transfer therapy (MTT) ■ 
stress urinary incontinence (SUI) ■ diffusion tensor imaging (DTI) ■ magnetic resonance 
imaging (MRI) 
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2.2 Introduction 
The quality of life of patients with urinary incontinence (UI) is significantly reduced 1,2. UI may 
affect 20-50% of all women 3, with health care expenditures of $65.9 billion in 2007 and 
projected costs of $82.6 billion in 2020 in the United States alone 4,5. Urinary continence is 
achieved by a complex interplay between the urethra, the rhabdosphincter, bladder neck 
position, detrusor muscle, nerve integrity, vascular plexus and the connective tissue support. 
Thereby, the rhabdosphincter prevents urine outflow by providing both resting urethral tone 
via slow-twitch fibers and rapid refectory contraction if the abdominal pressure rises. Any 
damage to the sphincter muscle, linked nerves or the surrounding tissue, e.g. during 
childbirth, by surgical treatments of the lower urinary tract or aging, may result in UI. While 
current treatment options, e.g. physical exercise, medication or surgery only show limited 
success as well as extensive variability within the patient population 1,2, bioengineering of 
tissues might meet those challenges.  
Muscle regeneration after injury and necrosis follows strictly regulated, time-dependent 
steps. Minutes after the injury, an acute inflammation is initiated, which lasts for about 2 
weeks. The injured area is invaded by polymorphonuclear leukocytes and macrophages. 
These cells actively secrete chemokines, cytokines, growth factors and NO, reactive oxygen 
species and proteases. This mix of cell- and ECM-derived substrates released during the 
inflammation process leads to the initiation of muscle regeneration 6,7through resident 
satellite stem cells (SSCs) 8. SSCs are considered a heterogeneous, quiescent adult stem 
cell population located between the sarcolemma and the basal membrane of muscle fibers 
and account for 2-5% of identifiable nuclei in muscle tissue 9,10. After trauma or damage, 
SSCs participate in tissue regeneration by proliferating and differentiating into myoblasts and 
later fuse to form new myofibers. 
Engineered tissues generated from harvested stem cells, such as skeletal muscle precursor 
cells and activated SSCs (aSSC), that were injected directly or implanted into the body in 
combination with a biocompatible carrier material, have been investigated as a treatment for 
stress UI (SUI) and other (genetically) acquired myopathies 11–15. Ongoing clinical trials are 
trying to confirm these results for patient application. Clinical trials with UI patients showed 
no signs of rejection or other side effects, proving that the application of autologous cells for 
skeletal muscle regeneration is feasible, safe and ready for the “bench to bedside” transfer.  
SSC transplantation imitates the tissue response upon injury. Nonetheless, for long-term 
functional tissue restoration, myofiber restoration is not sufficient, but self-restoration upon 
recurring damage must also be secured. The use of injectable cultured aSSCs for the 
treatment of SUI has been investigated in rodent and canine models, where its potential to 
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become the first treatment to restore sphincter muscle function has been shown 12,14,16. 
These cells provide overall safe muscle regeneration even for patients with previous medical 
history of cancer, preventing cancer recrudescence by secretion of paracrine TNFα and 
through inhibition of tumor growth 17. First clinical studies revealed no negative side effects 
after myoblast transfer therapy (MTT) 18,19,7. These cells can be isolated from patients of all 
ages and both sexes, forming new skeletal muscle tissue over time 6. Their in vitro growth 
potential and functional output after transplantation permits autologous transplantation within 
3 weeks after muscle biopsy 6. The majority of SSCs are committed to the myogenic lineage 
16 and are therefore most suitable for muscle engineering: Investigations on the use of 
injectable cultured human aSSCs (haSSC) for the treatment of SUI in small animal models 
were highly promising 8,10,9,20.  
However, cell follow-up after transplantation and the training of the engineered muscle tissue 
are necessary to ensure a consistent and long-lasting therapeutic benefit. Unfortunately, the 
evaluation of MTT (and any other cell therapy approach) is challenging, as it mainly relies on 
indirect measures, e.g. pre- and post-injection pad tests, diary of incontinence episodes and 
quality of life surveys. Evidently, a non-invasive monitoring system for reliable treatment 
monitoring is highly desirable. Magnetic resonance imaging (MRI) techniques bear the 
potential to monitor tissue regeneration and determine efficiency and functionality of matured 
tissue without destructive and invasive tissue sampling.  
In biological tissue, water diffusion is restricted by cell membranes as well as intracellular 
structures, which can be measured using MR diffusion-weighted imaging (DWI). DWI is 
based on the addition of two equal magnetic field gradients with opposite orientation, where 
the first gradient de-phases and the second gradient re-phases the proton spins. With no or 
only limited movement of the spins, a high signal can be observed due to an almost complete 
refocusing of the spin signal. However, diffusion of the spins between the two gradients will 
eventually result in an attenuated signal as not all spins can be refocused by the latter 
gradient 21. Moreover, water diffusion in structured tissue, such as neurons or skeletal 
muscle, is anisotropic. MR diffusion-tensor imaging (DTI), an extension of DWI, measures 
anisotropy per pixel and provides the directional information relevant for MR tractography or 
fiber tracking in vivo 22. While applications of DWI and DTI have always been largely focused 
on neurological disorders 23,24 they represent promising tools to monitor a wide variety of 
diseases in regions outside of the brain including the spinal cord 25, liver 26 or muscle 27–30. 
Both, DTI and tractography can easily be combined with other MR imaging techniques and 
modalities to obtain comprehensive tissue characterization 31.  
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In tissues such as brain grey matter, apparent diffusivity is largely independent of the 
orientation of the tissue and therefore isotropic. In oriented tissues, such as the skeletal 
muscle or brain white matter, however, measured diffusion depends on the structural 
organization of the tissue 32. Since water diffusion is restricted by cell membranes in healthy 
tissue, the apparent diffusion coefficient (ADC) of the water compartment is expected to be 
increased when cellularity is reduced 33. After skeletal muscle tissue damage, the diffusion of 
water, proteins and cells into the damage site influence the anisotropy of muscle 
architecture, which is defined through the diffusion tensor eigenvalues (λ1, λ2, λ3), and 
indices of diffusion anisotropy such as fractional anisotropy (FA). They provide information 
on the local tissue microstructure and geometry change 34. Our study investigated the 
potential of DTI to determine the regeneration after myoblast transfer therapy. DTI has 
proven invaluable for the study of skeletal muscle fiber architecture in humans and small 
rodents 29,35,36. Furthermore, DTI has proven to be applicable to show tissue recovery after 
femoral artery ligation and ischemia-reperfusion in mouse skeletal muscle 30,34 as well as in 
tissue denervation 37. However, to our knowledge, this is the first study to utilize DTI and fiber 
tracking in order to follow skeletal muscle tissue regeneration after aSSCs treatment of an 
injured muscle. In this study, we aimed to monitor skeletal muscle regeneration after MTT, 
using DTI and MR Tractography measuring the integrity and length of regenerating muscle 
fibers in a small animal muscle crush model.  
2.3 Materials and Methods  
Study design 
To apply DTI for the monitoring of stem cell supported muscle fiber regeneration in an in vivo 
muscle crush model, haSSCs were injected in a model of acute muscle injury. Regeneration 
was examined via MRI after 1, 3, 7, 14 and 21 days, with succeeding tissue harvest of the 
de-novo muscle tissue at days 3, 7, 14 and 21 (Figure 1). Tissue samples were analyzed by 
immunohistochemistry and haematoxylin-eosin staining. Injections were performed in three 
groups: haSSCs (n=9), collagen (n=3) and phosphate buffered saline (n=3) in mice that 
previously underwent a standardized muscle crush treatment of the tibialis anterior (TA) 
muscle. 
Cell culture 
We derived haSSCs from rectus abominis samples obtained of female patients (n=3, age 
55±5) undergoing abdominal surgery after providing informed consent. Tissue isolation was 
approved by the local ethics committee (Kantonale Ethikkommission Zürich, license no StV 
01/2008 and 2016-02171). The cells were isolated and cultured as described previously 38. 
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Briefly, muscle biopsies were soaked in iodine (3 min), iodine-PBS (1:1; 3 min) and washed 
in PBS until all iodine was removed. After macroscopic dissection of adipose tissue, the 
muscle biopsies were minced with a surgical scissor in 0.4% dispase (Gibco, Grand Island, 
NY, US) / 0.2% collagenase type I (Worthington Biochemical, Lakewood, NJ, US) and 
digested (60 min, 37°C). Dispase / collagenase activity was blocked with Dulbecco’s 
Modified Eagle’s Medium / F12 (Gibco) supplemented with 10% Fetal Bovine Serum (FBS; 
Sigma, St. Louis, MO, US). The cell suspension was filtered through a 100 µm cell strainer 
(Corning, Corning, NY, US) and transferred into collagen type 1 pre-coated cell culture dish 
(Corning). After 24 h, the non-adherent cells were transferred to a second pre-coated culture 
dish in order to remove fibroblasts. The growth media for the cell isolation and expansion 
consisted of DMEM/F12 supplemented with 18% FBS (Sigma), 1% penicillin / streptomycin 
(Gibco and Invitrogen, Carlsbad, CA, US), human epidermal growth factor (10 µg/ml, Sigma), 
human basic fibroblast growth factor (1 µg/ml, Sigma), human insulin (10 µg/ml, Sigma), and 
dexamethasone (0.4 µg/ml, Sigma). The cells were subcultivated on standard tissue culture 
polystyrene dishes and passaged when reaching 80%–90% confluency. 
Surgery and cell injection  
The local veterinary authorities (Veterinary Office of the Department of Health of the Canton 
of Zurich, license no. 99/2013) approved all animal experiments. We injected haSSCs into 
the crushed TA muscle of female nude mice (Crl:CD1-Foxn-1nu; Charles River Laboratories, 
Sulzfeld, De). The animals were anesthetized with 3% isoflurane (1-Chlor-2,2,2-trifluorethyl-
difluoromethylether; Attane, Provet, Lyssach, CH), and received Buprenorphine; (0.1 mg/kg 
BW s.c., Temgesic, Reckitt Benckiser Healthcare, Wallisellen, Switzerland) pre-operative (15 
min) and again if signs of post-operative pain occurred (as defined by the score sheet). 
After cell expansion (passage 4), cells were labelled with PKH-67 (PKH67GL-1KT, Sigma) 
according to the manufacturer’s recommendation. The reaction was blocked by FBS [1:1]. 
The cells were washed twice with culture medium and in 1xPBS in order to remove surplus 
dye material. Cells were resuspended in 1.5% collagen type I solution (Corning): (7:10) + 
MEM (1:10) + NaHCO3 [23.4 mg/ml] (2:10).  
Prior to the injection, the animals were subjected to a mechanical muscle crush injury of the 
anterior tibialis muscle 39. For the crush injury, a lateral incision through skin and fascia lata, 
starting from the talocrural region up to the knee was made with an iris scissor (Wagner KG 
Klinikbedarf, Remscheid, DE). The coronal plane between the TA and the extensor digitorum 
longus (EDL) was separated. The lower jaw of an artery forceps was inserted between the 
TA and the EDL, so that the top jaw rested on the superior surface of the TA. The crush 
injury was then performed by pressing the forceps until reaching a given mark on the holders 
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for 3 s. The haSSC-collagen solution (6*107 cells / ml collagen type 1; injection volume 30 µl) 
was injected into the left and right TA. Control animals received an equal volume of either 
PBS or collagen type 1 without cells. The site of injury and the wound was closed with 
Ethikon Vicryl 5-0 resorbable suture material. The crush injury was applied to both hind limbs 
of each mouse. After surgery, animals were placed in a warmed cage for recovery. 
MR imaging 
Mice were subjected to MR imaging analysis post-operative day POD 0 (=baseline) and POD 
1, 3, 7, 14 and 21. During the imaging process, mice were anesthetized with 1.8-3.0% 
isoflurane and placed in prone position on a respiratory sensor (SA Instruments, Stony 
Brook, NY, USA) located in a plastic holder with nose cone and covered by a warming pad to 
maintain body temperature. Vitamin A ointment was used to prevent dryness of the eyes 
during the imaging process. All measurements were performed with a Bruker 4.7-T 
Pharmascan 47/16 unit (Bruker BioSpin MRI GmbH, Ettlingen, Germany). 
Subsequent to a gradient-echo localizer scan in three spatial directions, an axial and sagittal 
T2-weighted, two-dimensional fast spin-echo sequences (2D-RARE) imaging protocol with 
time-to-echo (TE) = 33 ms/ time-to-repetition (TR) = 2500 ms, number of averages (AVG) = 
2, receiver bandwidth (BW) = 50000 Hz, echo train length = 8, echo spacing = 11.0 ms, field 
of view (FoV) = 40 x 40 mm, slice thickness = 1.5 mm, matrix 256 x 256, voxel size = 0.156 x 
0.156 x 1 mm was recorded to cover the leg in 20 slices. The duration of the scan was 1 min 
20 s. 
A diffusion-weighted spin-echo MR sequence was used for DTI and tractography. The 
diffusion gradients were applied in six non-collinear directions, and one reference image was 
obtained without diffusion weighting. The in-plane resolution was 0.3125 mm. Imaging 
parameters were as follows: FOV = 40 x 40 mm2, TE = 22.8 ms / TR = 6000 ms, matrix 128 x 
64, 1 mm section thickness, 1 mm intersection gap, four sections, two acquired signals, 
diffusion gradient separation time = 13 ms, diffusion gradient duration = 8 ms, and a b-value 
of 450 s/mm2. The duration of the scan was 90 min. 
DTI parameters 
For every muscle eigenvalues (λ1, λ2 and λ3), mean diffusivity (MD), and fractional anisotropy 
(FA), according to (1) and (2) (D=diffusion tensor were calculated: 
    
 
 
          
λ       
 
     
(1) 
Apparent Diffusion Coefficient (ADC) measures the diffusion of water molecules within 
tissue. A low mobility of water molecules corresponds to a low ADC value 40. 
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(2) 
Fractional anisotropy (FA) represents the anisotropy of water motion ranging from 0 
(isotropic movement of water) to 1 (anisotropic movement of water molecules), (λ1>>λ2=λ3) 
41. 
   
     
 
 
(3) 
Radial anisotropy (RA), the average of the second and third eigenvector, represents the 
flow perpendicular to the major structure, e.g. an axon or a muscle fiber, representing the 
magnitude of the shortest axes of the elliptical area of diffusion 42. 
      (4) 
Axial anisotropy (AA) or first eigenvector, represents the flow in parallel along the major 
structure, e.g. an axon or a muscle fiber, representing the magnitude of longest axes of the 
elliptical area of diffusion 42. 
Region of interest (ROI) selection and fiber tracking 
MR data analysis was done using DTI-Studio (http://dsi-studio.labsolver.org/). Paravision 
files were converted to an NIFTI image format. For three-dimensional visualization of the 
regenerated muscle, a region of interest (ROI) was manually drawn in the axial, coronal 
and/or sagittal planes.  
For each muscle or muscle group, the DTI parameters were calculated at multiple points per 
fiber along the fiber tracts. The corresponding T2w anatomical image was used as a 
reference. A deterministic fiber tracking algorithm 43 was used. The anisotropy threshold was 
0.04. The angular threshold was 30 degrees and, step size was 0.3 mm. The fiber 
trajectories were smoothed by averaging the propagation direction with 80% of the previous 
direction. The seed points were set as follows: tracking index = 0, FA threshold = 0.04, 
turning angle = 30°, step size = 0.3, smoothing = 0.8, min length = 5, maximal length = 50, 
initial direction = 0, seed plan = 1. Tracks with a length less than 16 mm were discarded. A 
total of 10’000 tracts were calculated. 
Morphological analysis 
Dissected tissue of de novo-formed muscle was placed in tissue optimum cutting 
temperature (OCT) compound embedding medium (Cell Path; VWR, Zurich, Switzerland) 
immediately after isolation. Tissues were cut into 12 μm cryostat sections (CM1850, Leica 
Biosystems, Wetzlar, DE); average blade temperature was -20 °C and the sample 
temperature was around -20 °C. Cryosections were placed onto Superfrost Plus slides 
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(Thermo Scientific) and stored at -20 °C until use. Images were acquired with Leica 
DFC7000T (Leica Microsystems, Wetzlar, DE) at 20x or 40x magnification. 
Immunofluorescence 
Cryosections were air-dried for 30 min at 37 °C and fixed (4% PFA in PBS for 20 min), 
permeabilized (0.5% Triton X-100 in PBS; 15 min) and blocked (3% BSA + 0.1% Triton X-
100 in PBS; 60 min). Cryosections were stained with anti-MyHC (1:5; NA4; Developmental 
Studies Hybridoma Bank, University of Iowa, Iowa City, IA, US) or anti-α-sarcomeric actinin 
(1:100; A7811, Sigma) overnight at 4 °C. After washing with PBS, the tissues were incubated 
with Cy3 anti-mouse IgG secondary antibody (1:1000; C2181, Sigma) and 4’,6-Diamidin-2-
phenylindol (DAPI; 1:200; D9542, Sigma) for 1 h at room temperature, washed again, and 
finally mounted (Dako). For image acquisition, exposures were normalized to unstained 
controls (secondary antibody and DAPI only). 
Haematoxylin and eosin staining 
Cryosections were air-dried for 30 min at 37 °C, fixed in 4% PFA-PBS solution for 20 min, 
and rinsed in PBS. The tissue samples were placed in haematoxylin for 10 min and 
thereafter rinsed with cold water for 2 min. The slides were dipped in HCl-EtOH (1% in 70% 
EtOH) before placing them in Eosin for 30 sec. The Cryosections were dehydrated in 70% 
EtOH, 96% EtOH, absolute EtOH and cleared in Xylol. The slides were covered with Pertex 
(Histolab, Gothenburg, SWE). 
Statistics 
Experiments were repeated with three human muscle biopsies. Data was analyzed by one-
way analysis of variance (ANOVA) test. The results are presented as mean values ± 
standard deviations, and P values below 0.05 were considered to indicate a significant 
difference. The parameters were considered as normally distributed data. From these data 
points, the mean value for each of the parameters was calculated. Per muscle data set, all 
subjects were combined to express a mean value ± standard deviation (SD). Percentage 
changes of values are expressed as mean value ± error propagation of SD. 
2.4 Results 
We assessed the changes of tissue water diffusion properties (described by FA and ADC 
values as well as fiber tract number, volume and length) over time (21 days) in a haSSCs 
supported small animal muscle crush model. The MRI data were compared with histology 
and immunofluorescence imaging. The three applied treatment options were injections at the 
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site of the injury with 1) haSSCs in a collagen type 1 carrier solution, 2) collagen type 1 or 3) 
PBS. 
Tissue formation 
Tissue regeneration was shown in all three-study groups. During regeneration, the changes 
in tract volume, tract number and tract length were recorded by computer tractography of the 
same individual for up to 21 days. Tractography of healthy TA (n = 36) shows an initial tract 
number of 198 ± 56, a tract volume of 35.75 ± 9.06 mm3 and a tract length of 9.08 ± 1.13 
mm. During the period of tissue regeneration, breathing and movement artefacts had a 
negative influence on subsequent fiber tractography. Exemplary longitudinal tractography of 
the regeneration TA muscle (Figure 2). The haematoxylin eosin staining to assess the tissue 
formation after therapeutic intervention showed no significant differences between the three 
treatment options when compared to corresponding time points of the other treatment groups 
(Figure 3b and 4). At POD 3, all samples exhibited a high presence of immunomodulatory 
cells, decreasing at POD 7. The region of injury showed no presence of skeletal muscle 
fibers at day 3 and 14. On POD 14 regenerated skeletal muscle fibers at the region of injury 
were present together with a population of infiltrating cells, which were absent as of POD 21. 
The expression of skeletal muscle associated proteins myosin heavy chain and alpha-
sarcomeric actinin could be detected for all three conditions on POD 14. The expression of 
these proteins is maintained onwards during the remaining regeneration period until day 21 
as shown by indirect labelling with corresponding primary and secondary antibodies (emitting 
red light after excitation). The detection of haSSCs at the site of regeneration was possible 
due to the initial PKH-67 membrane labelling (emitting green light when excited). haSSCs 
have fused either with existing unharmed myofibers after the injury or with host satellite cells 
resulting from self-regeneration. 
Diffusion tensor imaging 
To characterize the diffusion characteristics of healthy and regenerating mouse TA muscle, 
the mean FA and ADC parameters were calculated from the DTI datasets. Baseline values of 
intact TA muscle was determined in all animals. The initial FA was 0.251 ± 0.047 mm2/s and 
ADC was 1.182 ± 0.094 x10-3 mm2/s (n=36). 
Upon application of injury and the subsequent treatment intervention, ADC values increased 
from the initially measured values on POD 0 (in x10-3 mm2/s: collagen 1.174 ± 0.077, 
haSSCs 1.197 ± 0.094 and PBS 1.129 ± 0.106) across all experimental cohorts on POD 1 (in 
x10-3 mm2/s: collagen 1.401 ± 0.077, haSSCs 1.473 ± 0.120 and PBS 1.480 ± 0.094). The 
values remained increased on POD 3 compared to healthy muscle; however, they were 
approaching baseline measurements compared to POD 3 (in x10-3 mm2/s: collagen 1.353 ± 
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0.077 haSSCs 1.332 ± 0.111 and PBS 1.358 ± 0.117) approximating baseline values on 
POD7 (in x10-3 mm2/s: collagen 1.200 ± 0.108, PBS 1.235 ± 0.115) or falling below (in x10-3 
mm2/s: haSSC 1.176 ± 0.094). Values in all study groups fell below initial values of healthy 
muscle on POD 14 (in x10-3 mm2/s: collagen 1.119 ± 0.105, haSSC 1.163 ± 0.129 and PBS 
1.121 ± 0.034). On POD 21 values remained below POD 0 when treated with collagen (in 
x10-3 mm2/s: 1.110 ± 0.072) and haSSC (in x10-3 mm2/s: 1.166 ± 0.103) but increase when 
treated with PBS (in x10-3 mm2/s: 1.173 ± 0.088) (Table 2).  
Percentagewise, the change in ADC in relation to healthy muscle was +23.03% ± 11.61 after 
haSSCs treatment, and +31.13% ± 9.26 or 19.3 % ± 11.44 after PBS or collagen treatment, 
respectively. On POD 3, these values remained increased (haSSCs: 11.25 ± 14.91%, PBS: 
20.26% ± 21.10, and collagen: 15.27 ± 11.29%). While deviation from healthy tissue was 
lowest on POD 1 when treated with haSSCs, the PBS and collagen treated animals 
expressed similar values. Changes from POD 1 to POD 3 were 3.32% ± 8.09 for collagen 
treatment, 9.67 % ± 13.31 after MTT and 8.24% ± 21.08 when PBS was injected into the 
injury site (Table 1). 
Post-operative FA values decreased in all three study groups. Percentagewise, FA changes 
in relation to healthy muscle were -29.5% ± 7.58 after haSSCs treatment and -43.54% ± 8.18 
or -25.31% ± 8.03 after PBS or collagen treatment, respectively. On POD 3, these values 
remained lower compared to POD 0 (haSSCs: -8.21% ± 4.18, PBS: -25.35% ± 5.02 and 
collagen: -17.51% ± 3.9). Changes from POD 1 to POD 3 were 9.83% ± 15.46 for collagen 
treatment, 29.61% ± 14.99 after MTT and 35.49% ± 26.87 when PBS was injected into the 
injury site (Table 1). 
In absolute terms, FA values decreased from baseline values measured on POD 0 (collagen 
0.254 ± 0.035, haSSCs 0.240 ± 0.031 and PBS 0.291 ± 0.085) to POD 1 (collagen 0.190 ± 
0.049, haSSCs 0.169 ± 0.040 and PBS 0.164 ± 0.030). Values remained lower on POD 3 
compared to healthy muscle, but higher in comparison to POD 1 (collagen 0.210 ± 0.026, 
haSSC 0.220 and PBS 0.217 ± 0.056). On POD 7, collagen equaled baseline measurements 
(0.253 ± 0.041) while mice receiving MTT had a higher FA value than measured initially 
(0.278 ± 0.039) and FA values remained lower after treatment with PBS (0.245 ± 0.042). 
On POD 14, the FA value for collagen treated mice remained at the level of POD 7 (0.253 ± 
0.046). Measurements in haSSC treated mice showed a decline on POD 14 (0.273 ± 0.048) 
while PBS treated mice now showed an increased value compared to baseline (0.288 ± 
0.018). On POD 21, FA values fell in all conditions (collagen: 0.249 ± 0.056; haSSCs: 0.270 
± 0.026; PBS: 0 0.235 ± 0.033 [mean ± SD] (Table 2). The values for collagen-treated mice 
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remained near POD 0, while those for haSSC treated mice remained increased and the 
values for PBS treatment fell below POD 0. 
Although no significant differences could be observed amongst the investigated study 
groups, there were time-dependent and statistically significant differences among PODs 
within each study group (Table 3). 
2.5 Discussion 
The rhabdosphincter, like any other skeletal muscle tissue, is a highly ordered, dynamic, 
structurally stable tissue, composed of longitudinally aligned contractile fibers arrayed within 
sheaths of connective tissue and extracellular matrix 16. It is supplied with oxygen and 
nutrients by a dense network of blood vessels. While little tissue turnover occurs under 
homeostatic conditions in vivo, the muscle fibers undergo physiological changes (atrophy, 
hypertrophy, or fiber type switch) under physical activity. Adult skeletal muscle is able to 
regenerate from damage to sarcolemma or myofibrils inflicted by muscle contraction, without 
inducing an inflammatory response and under preservation of morphological and functional 
features 17,18. However, when exposed to high forces, destruction of muscle fibrils, fibers or 
entire tissue segments occur. In this case, native tissue regeneration undergoes a second / 
inflammatory phase as well as a repair and remodeling phase. Although skeletal muscle 
shows remarkable regeneration capability, it is unable to cope with larger injuries, such as 
focal and volumetric loss 19, resulting from chronic inflammation / fibrosis or aging 44,45. This 
issue may be overcome by injection of stem cells, which allows structural reconstruction and 
improves contractile function 8,46. 
The activation of SSCs can be induced intrinsically 47 or by extrinsic signals, e.g. muscle 
injury, initiating myogenesis. The activation and subsequent myogenic differentiation of 
quiescent SSCs (qSSC)is controlled by diverse myogenic regulatory factors (MRFs) initiating 
the transformation to aSSCs. Upon activation, committed aSSCs migrate out of the sub-
laminar niche and the differentiation into fast proliferating myoblasts 48 begins. After reaching 
terminal differentiation, myoblasts withdraw from the cell cycle, elongate and start expressing 
myosin heavy chain and sarcomeric α-actinin. These terminally differentiated myocytes fuse 
to multinucleated myotubes, further align to myofibers and finally form mature skeletal 
muscle 49. In addition, the initial increase of ADC may be accelerated by local inflammation or 
edema 50. 
The FA and ADC values of the healthy TA measured in our study are in line with previous 
literature. However, to our knowledge, we are the first group to investigate the MTT-mediated 
tissue regeneration using DTI. Heemskerk et al. extensively described the application of DTI 
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in human and murine skeletal muscle (reference number here?). Their study was the first 
study of its kind and showed the applicability of DTI when studying the mouse hind limb 
anatomy 29. The extent of changes of FA and ADC in the injured muscle area depends on 
type of injury and extent of inflammation (swelling, edema and the infiltration of immune 
cells). As described by Heemskerk et al. and others, diffusion properties to some extent are 
not only defined by tissue properties but also by cell size and morphology 30,52. Time course 
of injury progression and initiation of tissue regeneration until POD 3, for both histological as 
well as MRI measurements, correlate with findings (e.g. 53,54). Compared to healthy skeletal 
muscle, the FA values decreased and ADC increased in all three injury/treatment conditions 
to a similar extent as the tissue architecture and therefore spatial anisotropy was disrupted: 
Without the spatial restriction of the muscle fibers, the environment switched from anisotropic 
to isotropic. This observation goes hand in hand with the influx of immune cells and the 
expansion of local cells due to inflammatory processes, cell proliferation and osmosis to 
maintain physiological molecule concentrations within the tissue. Changes in FA and ADC 
after muscle crush injury are similar to those of ligation or denervation injury 51. As reviewed 
by Sotak, diffusion changes are a function of intracellular-extracellular water homeostasis, 
and therefore are a sensitive marker of ionic equilibrium55. This changes upon tissue rupture, 
cell membrane depolarization and cell volume changes such as cellular swelling, growth 
during cell cycle or loss of cell volume 56. Hence, presence and orientation of barriers are due 
to translational motion, extracellular space tortuosity, and the integrity of cellular membrane 
57,58. 
Tractography shows a one-directional tissue development in line with histological findings, 
indicating that this is an important factor for the de novo synthesis of muscle fibers, and 
therefore also essential to establish a functional bioengineered skeletal muscle tissue. 
Potential shortcomings of this study 
As mentioned by Heemskerk et al. 35 inconsistency in the DTI parameters may be the result 
of different DWI acquisition protocols (coil positioning, B0 drift, gradients, shimming) as well 
as differences in tissue water diffusion, architecture and physiological conditions. 
Nevertheless, clinical feasibility and repeatability of DTI-based skeletal muscle imaging and 
especially of the female pelvic floor has been shown previously 24,32,52.  
Although the echo planar imaging MRI modality as used in this study is of short duration, 
image artefacts such as blurring, signal dropout, and ghosting due to either its sensitivity to 
magnetic susceptibility contrast or the eddy currents generated by its rapid gradient 
switching, occur 62. Furthermore, possibly due to variation in analytical methods, there is a 
heterogeneity in skeletal muscle DTI parameters 63. 
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Moreover, the applied injury model used in this study imitates acute muscle associated with 
fast self-regeneration of 21-28 days. We observed this process in our study in all three 
experimental groups. The muscle crush lesion performed in this study causes a blunt trauma 
without any laceration along the sarcolemma of the TA. Therefore, the muscle extracellular 
matrix remains intact and may serve as a template for endogenous muscle regeneration 59–61. 
Nevertheless, our standard animal model mimics the rhabdosphincter destruction (resulting 
e.g. from childbirth) more closely than other injury models. Laceration for instance would not 
have caused damage to the muscle fibers, while cardiotoxin requires long recovery and 
volumetric muscle loss as well as ischemia is not described for urinary incontinence. In order 
to realize the full potential of rhabdosphincter cell therapy, optimized animal models such as 
cre-flox-mediated Pax7+ cell depletion to inhibit self-regeneration must be considered. 
Furthermore, functional data (e.g. myography) might allow a correlation of DTI and functional 
regeneration. 
Future directions / practical application 
The use of aSSCs in human patients to treat SUI is considered save 19. Our results reveal a 
non-invasive monitoring tool for the analysis of skeletal muscle bioengineering in human 
patients, where other imaging tools do not allow sufficient access. These findings will soon 
be applied in a clinical phase 1 trial performed by our research group. Unlike several 
previously performed studies without longitudinal in vivo imaging18,19,7, the DTI in our study 
might help to find the optimal method for myoblast transfer, considering the various 
approaches in clinical trials (e.g. minced muscle tissue 64 vs. expanded myoblast 18,19,7). This 
will be one of the first in man applications of non-invasive imaging in rhabdosphincter cell 
therapy. 
DTI and tractography may not only enable direct visualization of tissue regeneration but also 
offer insight into microstructural anomalies in the pelvic floor. This will allow to determine the 
clinical applications as well as the time point of intervention with the best outcome for the 
patients. So far, DTI and fiber tractography have been applied only in grey and white matter 
tracts of the spine and the cerebellum, but they may bear the potential as diagnostic tools 
also for other biological tissues. DTI and fiber tractography-visualization of the female pelvic 
floor using standard clinical MRI-device has been proven feasible 27. However, limitations 
due to gas artefacts, bowel movement or imaging repeatability (imaging protocol, noise and 
artefact characteristics, and the fiber tracking algorithm 35) must be overcome. Differences in 
endpoint values may be due to physiological properties of the tissue. Zijta et al. showed, that 
within a patient, FA and ADC properties differ between different skeletal muscle tissues of 
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the pelvic floor 27 and Sinha et al showed 65 that DTI-based fiber tracking of the male urethral 
sphincter is feasible. 
2.6 Conclusion 
In summary, we could show that DTI not only allows imaging of healthy skeletal muscle but 
also permits the monitoring of self- / cell therapy-mediated tissue regeneration of anisotropic 
tissues. The technology is suitable to follow regeneration in animal models but most 
importantly can also be applied in clinical trials, e.g. for the follow up after treatment of UI 
with MTT. 
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2.8 Tables 
Table 1: 
Percentagewise changes of fractional anisotropy (FA) and apparent diffusion coefficient (ADC) of the assessed 
TA muscles on POD 1 and POD 3 compared to values prior to intervention 
 
 ∆ FA ∆ ADC 
 Collagen haSSC PBS Collagen haSSC PBS 
∆ POD0:POD 1 25.31% 33.44% 35.33% 19.30% 25.46% 26.09% 
∆ POD 0:POD3 17.51% 13.34% 14.49% 15.27% 13.45% 15.63% 
∆ POD 1 :POD 3 28.06% 40.93% 23.95% 11.36% 11.70% 9.01% 
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Table 2: 
Mean and standard deviation (SD) after computation of fractional anisotropy [mm
2
/s] (FA) and apparent diffusion coefficient (ADC) of the assessed TA muscles. 
 
 
FA ADC 
collagen hSSC PBS collagen hSSC PBS 
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POD 0 0.254 0.035  0.240 0.031  0.291 0.085  1.174 0.077  1.197 0.094  1.129 0.106  
POD 1 0.190 0.049 0.3735 0.169 0.040 <0.0001 0.164 0.030 <0.0001 1.401 0.112 0.0332 1.473 0.120 <0.0001 1.480 0.094 <0.0001 
POD 3 0.210 0.026 >0.9999 0.220 0.042 0.0032 0.217 0.056 0.7245 1.353 0.077 >0.9999 1.332 0.111 0.0012 1.358 0.177 0.8727 
POD 7 0.253 0.041 0.9320 0.278 0.039 >0.0.003 0.245 0.042 0.9995 1.200 0.108 0.5434 1.176 0.094 0.0001 1.235 0.115 0.8755 
POD 14 0.253 0.046 >0.9999 0.273 0.048 >0.9999 0.288 0.018 >0.9999 1.119 0.105 0.998 1.163 0.129 >0.9999 1.121 0.034 0.9173 
POD 21 0.249 0.056 >0.9999 0.270 0.026 >0.9999 0.235 0.033 0.7354 1.110 0.072 >0.9999 1.166 0.103 >0.9999 1.173 0.088 >0.9999 
Non-invasive monitoring of skeletal muscle regeneration after human-derived myoblast transfer therapy in mouse 
hind limb via diffusion-tensor imaging 
Figures 
47 
2.9 Figures 
Fig. 1: 
 
Scheme with time axis showing the experimental setup. Cells gained from muscle biopsies have been expanded 
in vitro for 13 days. After baseline imaging to assess imaging data from healthy TA muscles, mice received thera-
peutic intervention and were monitored for up to 21 days. 
  
Time [d]
Biopsy from healthy 
human muscle donor
Fibroblast reduction-step
Baseline imaging
Muscle Crush Injury 
and Cell Injection
Time Points for MR-Imaging 
and tissue isolation
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Fig. 2: 
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Representative sample showing changes in tract volume, tract number and tract length during the period of re-
generation. Below is the computed tractography of the same individual animal showing tractography of aSSC-
supported tissue regeneration.  
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Fig. 3: 
 
A) Changes in MR indexes before and during the timespan of muscle regeneration after intervention. Data are 
mean values of the experimental groups (collagen: n = 3, PBS: n = 3, haSSC: n = 9). ADC (in x 10-3 mm
2
/sec) 
and FA are shown as original data, normalized by the baseline value of the uninjured TA of every animal prior to 
injury and therapeutic intervention. B) Representative images of H&E staining show the myogenic differentiation 
of the TA on POD 3 and 7 after MTT haSSCs in a collagen-carrier, respectively with the injection of collagen and 
PBS alone. Whilst haematoxylin stained nuclei appear blue, eosin stains proteins non-specifically pink.   
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Fig. 4: 
The development myofibers after injury and treatment with haSSCs, PBS and collagen respectively over the time 
span of 21 days were visualized with haematoxylin / eosin staining (nuclei appear blue, proteins in pink), revealing 
newly formed myofibers at the site of injury after 14 and 21 days of regeneration (The scale bar is 200 μm). Ex-
pression of skeletal muscle associated contractile proteins (middle panel) and sarcomeric actinin (right panel) via 
cyanine-3 conjugated secondary antibody is shown in red signal. Nuclei are stained by DAPI appear in blue signal 
whilst haSSCs pre-labelled with prior cell transplantation are visible through a green signal. Expression of both, 
sarcomeric alpha actinin and Myosin Heavy Chain after MTT at POD 14 and 21 is similar to the expression after 
self-regeneration of host tissue (treatment with PBS or collagen) (The scale bar is 50 µm.) 
  
Non-invasive monitoring of skeletal muscle regeneration after human-derived myoblast transfer therapy in mouse 
hind limb via diffusion-tensor imaging 
Figures 
51 
 
T1 -, T2 - relaxometry and magnetization transfer MRI permit non-invasive monitoring of stem cell supported 
skeletal muscle regeneration on a murine tibialis anterior crush injury model 
Figures 
52 
3 T1 -, T2 - relaxometry and magnetization transfer MRI permit 
non-invasive monitoring of stem cell supported skeletal muscle 
regeneration on a murine tibialis anterior crush injury model 
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3.1 Abstract 
Stress Urinary incontinence (SUI) has a profound impact on the quality of life in a vast 
number of patients and urethral sphincteric deficiency represents the fundamental etiology. 
Preclinical investigations on autologous muscle stem cell transplantation for treating SUI 
emphasized the need for non-invasive imaging modalities tracking the differentiation of 
MPCs into muscle fibers for an early therapeutic evaluation. This study assessed muscle 
regeneration by multiparametric magnetic-resonance imaging (MRI) on a murine hind limb 
tibialis anterior (TA) muscle crush model (n=18 mice), followed by an injection of collagen 
embedded human muscle precursor cells (MPCs) isolated from the rectus abdominis from 4 
different donors (n=12 mice) respectively of collagen only (n=3) or PBS injection (n=3) 
serving as control. MRI assessment of the hind limb using a 4.7T MR Scanner prior to 
surgery and on post-operative day (POD) 1, 3, 7, 14 and 28 quantified longitudinal and 
transverse relaxation times, and the magnetization-transfer ratio (MTR) of the regenerating 
TA muscle. Tissue specimens were histologically examined by hematoxylin-eosin staining 
and immunohistochemistry.  
Neither collagen embedding of human MPCs during stem cell transplantation, nor collagen 
alone as widely applied scaffold in stem cell research did influence the retrieved MRI 
parameters delineating muscle regeneration of the TA with increasing longitudinal and 
transverse relaxation times as well as decreasing MTR. Histological examination proved that 
all study groups concluded TA regeneration, suggesting that murine MPCs cells contributed 
significantly to the muscle restoration. Our results show, that this murine TA crush model, 
ideally with radiation depleted satellite cells, does lend itself for advancing MR methodology 
for monitoring of stem cell therapy as possible treatment for SUI.  
3.2 Introduction 
Stress urinary incontinence (SUI), describing the involuntary leakage of urine, is a prevalent 
disorder affecting worldwide 200 million, mostly middle-aged and elderly people 1. Besides 
creating enormous healthcare costs, this common urogenital disease poses a severe burden 
on the patient’s life quality 2,3. For women, pregnancy and subsequent vaginal delivery and 
for men, radical prostatectomy represent the major risk factors for developing SUI, generally 
caused by insufficient detrusor contraction due to weakened muscles of the urethra and the 
pelvic floor 4,5. Currently, there are several therapeutic options available and yet, they are 
either of limited success or associated with complications as a consequence of invasive 
procedures 5,6. 
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Therefore the autologous transplantation of muscle stem cells at the site of impaired or 
inadequate muscle regeneration has been extensively investigated as a potential treatment 
of SUI 7. Satellite cells residing beneath the basal lamina of muscle fibers represent the main 
reservoir for muscle regeneration 8,9. After trauma or damage, quiescent satellite cells start to 
proliferate and differentiate, then also called muscle precursor cells (MPCs) or myoblasts 10, 
and fuse later on to form new myofibres 11, which were shown to contribute to the 
regeneration process of the striated urethral sphincter in a murine model 12,13. 
Consequently, within the last decade a number of preclinical and clinical trials have been 
conducted assessing the feasibility of autologous muscle stem cell transplantation for 
reconstructing damaged urethral sphincter musculature and thereby restoring sphincter 
muscle function. The results hold great promise to establish stem cell therapy as a future 
treatment of SUI 14-20. Especially the one year – respectively the two year follow-up studies 
delivered very encouraging results 16,17. However, it is a much-debated question in stem cell 
research as to whether or not transplanted stem cells for tissue regeneration should be 
embedded in scaffolding materials. There are certain disadvantages associated with the 
injection of cells devoid of biomaterials, such as poor long-term cell survival and lack of 
control over the location of the cells after implantation. This could be circumvented by the 
minimal invasive injection of hydrogel scaffolding materials such as collagen in combination 
with the transplanted stem cells, providing structural support, restraining the cellular motility 
and further protecting transplanted cells from adverse effects of the inflammatory response at 
the injured environment 21.  
Clearly, assessing the therapeutic success within regenerative medicine restricts or even 
precludes invasive measures such as tissue biopsies. Nevertheless, in view of evolving stem 
cell-based regenerative therapies, it is indispensable and crucial, though likewise 
challenging, to repeatedly evaluate non-invasively the therapeutic progress by monitoring 
muscle tissue regeneration 16. As magnetic resonance imaging (MRI) has proofed capable to 
provide detailed anatomical visualization of soft tissue 22-24, it therefore lends itself as non-
invasive outcome measure for muscle tissue regeneration. Several previous studies using 
MRI unraveled a significant amount of information on structural characteristics of the 
musculature examining the regeneration after injury in mice 25,26 and rats 27,28 Furthermore, 
MRI has been successfully applied to assess viability and differentiation of stem cells in 
mouse 29-31 and rat 32-34. Thereby, MRI characterized the dynamic changes of muscle tissue 
differentiation by measuring the relaxation time, diffusion properties or magnetization 
transfer, the latter describing a detectable MR contrast meditated by proton exchange 
between the macromolecularly bound protons, mainly associated to proteins, and the free 
waterous fluid pool of protons upon a saturation prepulse set deliberately at a given off-
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resonance frequency distinct from the water resonance frequency. And albeit all mentioned 
MR parameters closely reflect the course of the muscle tissue maturation, especially the 
diffusion properties and the magnetization transfer reveal rather structural, hence likely 
functional characteristics, of the developing muscle by delineating the fiber content and 
orientation as detected by diffusion weighted (DW-) MRI and the content of predominantly 
proteinaceous macromolecules in the maturing musculature as measured by magnetization-
transfer (MT-) MRI.  
A consecutive appraisal of the quality of the regenerated musculature is important for 
estimating its future function and thus, reliable and non-invasive markers reflecting the 
regenerative state of the developing musculature are needed for translating such a cell 
therapy approach into a clinical application. This study addressed two questions, (i) if MRI is 
suitable to non-invasively delineate the myogenic differentiation upon traumatic muscle injury 
on a murine tibialis anterior (TA) muscle crush model, mimicking damage inflicted during 
childbirth, in combination with a concurrent injection of muscle precursor cells, resembling a 
real scenario of stem cell-based regenerative therapies, and further to that, (ii) if collagen as 
commonly used hydrogel scaffolding material, providing the carrier matrix for cell therapies, 
interferes with the retrieved MR parameters. For that aim, we retrieved the T1- and T2 -
relaxation as well as the MTR of mice that underwent TA muscle crush with subsequent 
injection of collagen embedded MPCs isolated from the rectus abdominis muscle of 
consented volunteers respectively collagen (control) and saline (control) alone. 
3.3 Materials and Methods 
Study design  
This study on female athymic mice (CD-1 nude mice, Crl:CD1-Foxn1nu; Charles River 
Laboratories,  MA, USA) was approved by the local veterinary authorities (Veterinary Office 
of the Canton of Zurich, license no. 99/2013). Mice (nTotal =54; 23-28 g) at the age of 8-10 
weeks were kept under standardized conditions in accordance with the institutional animal 
care guidelines with a 12-hour day-night cycle and unlimited access to standard diet and 
water. Research staff conducting experiments has received special education and training 
accredited by the Federation of Laboratory Animal Science Associations (FELASA). 
This study comprised essentially two cohorts of mice with one cohort for non-invasive MRI 
monitoring of myogenic differentiation within the crushed TA in a longitudinal study design, 
while the other cohort requiring tissue harvest for histological examination of the myogenic 
differentiation at corresponding time points of the MRI experiments was assessed in a cross-
sectional study design after TA muscle crush.   
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The cohort of mice dedicated to multiparametric MRI assessment (nMRI = 18 mice) consisted 
of three subgroups examining the regenerating TA crush injury followed by: (i) the injection of 
collagen-embedded human muscle precursor cells (MPCs) isolated from the rectus 
abdominis from 4 different donors (n=12 mice), (ii) the injection of collagen (n=3) and (iii) the 
injection of PBS (n=3), respectively, serving as control. MRI assessment of the hind limb was 
performed one day prior to surgery and on post-operative day (POD) 1, 3, 7, 14 and 21. All 
tissue specimens were harvested for immunohistochemical analysis on POD 21 after 
completing all MRI experiments.  
The other cohort providing the correspondent histological examination (nHistology = 36 mice) for 
each MR measurement assessed myogenic differentiation of TA muscle crush followed by: 
(i) the injection of collagen-embedded human muscle precursor cells (MPCs) (n=12), (ii) the 
injection of collagen (n=12) and (iii) the injection of PBS injection (n=12) on POD 3, 7, 14 and 
21 with each three animals per time point. 
Cell Culture  
Human MPCs were extracted according to established protocols 35,36 from rectus abdominis 
muscle specimens obtained from informed and consented female patients undergoing 
abdominal surgery in the age 55±5 years (n=4). This procedure was approved by the local 
ethics committee (Ethics Committee of the Canton of Zurich, license no. StV 01/2008 and 
2016-02171. In brief, muscle biopsy samples were minced and digested for 40 min at 37°C 
and 5% CO2 in Dulbecco’s Modified Eagle’s Medium with F12 nutrient mixture (DMEM/ F12 
growth medium) (Gibco, Grand Island, NY, USA) supplemented with 0.4% dispase (Gibco) 
and 0.2% collagenase type I (Worthington Biochemical, Lakewood, NJ, USA). In order to 
eliminate fast-adhering fibroblasts, digested samples were centrifuged, filtered, and seeded 
on collagen type I coated six-well dishes for 24 hours before transferring the supernatant 
containing human MPCs to fresh collagen type I coated six-well dishes. The cells were 
further cultured in DMEM/ F12 growth medium supplemented with 18% fetal bovine serum 
(FBS) (Gibco), 1% penicillin and streptomycin (Gibco), 10 μg/ml human epidermal growth 
factor (Sigma-Aldrich, Buchs, Switzerland), 1 μg/ml human basic fibroblast growth factor 
(Sigma-Aldrich), 10 μg/ml human insulin (Sigma-Aldrich), and 0.4 μg/ml dexamethasone 
(Sigma-Aldrich) in standard tissue culture polystyrene dishes at 37°C and 5% CO2. For MPC 
aided muscle regeneration, cells were subcultured four times after initial isolation having 
reached 80%–90% confluency, washed in phosphate buffered saline (PBS) (Gibco) and the 
cell membrane was labelled with PKH-67 dye (Sigma-Aldrich) for cell tracking according to 
manufacturer instructions. For that purpose, 6 x 107 MPCs were resuspended in 3 ml 0.08% 
(v/v) PKH-67 and incubated for 5 min at room temperature. After quenching the reaction with 
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FBS, cells were washed twice with PBS and resuspended in 1 ml collagen carrier matrix in 
Minimum Essential Media (MEM) (2.7 mg rat tail collagen type I / ml MEM) (BD Biosciences, 
Bedford, MA; USA), and if needed, pH was readjusted to 7.2 with sterile NaHCO3. 
Animal Surgery  
For analgesia, 0.1 mg/kg bodyweight (BW) buprenorphine (Temgesic, Indivior, UK) was 
administered subcutaneously 30 min prior start of any surgical intervention. Subsequently, 
anaesthesia was induced by 5% (v/v) isoflurane supplemented oxygen (Attane, Minrad I, 
Buffalo, NY) in an enclosed container. After applying eye ointment, animals were fixed and 
anaesthesia was maintained with 2-4% (v/v) isoflurane supplemented oxygen administration 
via small nose cone during surgical intervention. After lateral incision on the hind limb the TA 
muscle was carefully inserted between the jaws of an artery forceps and the crush injury was 
induced by pressing the forceps until reaching a defined mark on the holders. After removing 
the forceps, 30 μl MPC-collagen suspension containing 1.8 x 106 MPCs was applied at the 
site of injury and the wound was closed with Ethikon Vicryl 5-0 resorbable suture material. 
The crush injury was applied to both hind limbs of the mouse. Having completed the surgical 
procedure, animals recovered in a warmed cage and if needed, buprenorphine (0.1 mg/kg 
BW, s.c.) was readministered within 3 hrs, thereafter analgesia with buprenorphine (0.1 
mg/kg BW, s.c.) was repeated on POD 1 and 2 if signs of pain occurred. 
Histology  
A separate cohort of mice were sacrificed for histological examination of regenerating TA on 
POD 3, 7, 14 and 21 after crush injury. The muscles specimens were excised, snap frozen 
and cryosections (8 μm) underwent hematoxylin-eosin (H&E) staining. Cryosections were 
rinsed after haematoxylin staining with acidified ethanol and placed into eosin solution, 
dehydrated through a series of graded alcohols, cleared in Xylol and sealed under coverslip 
with Pertex (Histolab, Goteborg, Sweden). For immunohistochemistry, dried cryosections 
were fixed in 4% PFA, permeablized in 0.1% Triton X-100 solution, blocked with 3% bovine 
serum albumin (BSA) and incubated with primary mouse antibodies against myosin heavy 
chain (MyHC) (1:1) (NA4 DHSB (Developmental Studies Hybridoma Bank)) respectively 
against α-Actinin (sarcomeric) (1:1) (A7811 Sigmal-Aldrich) (4°C, 12 hrs). The secondary 
indocarbocyanine Cy3-labelled antibody (rabbit anti-mouse IgG F(ab′)2 fragment–Cy3) 
(1:1000) (C2181 Sigma-Aldrich) was incubated together with DAPI (1:100) (2-(4-
Amidinophenyl)-6-indolecarbamidine dihydrochloride) (RT, 1hr). Samples were mounted with 
mounting media for fluorescent imaging and a cover slip.  
Magnetic resonance imaging 
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The animals were subjected to MR imaging the day before muscle crush injury and then on 
POD 1, 3, 7, 14, 21 measuring longitudinal and transverse relaxation times and the 
magnetization transfer ratio. For that purpose, mice were placed in prone position on a 
respiratory sensor (SA Instruments, Stony Brook, NY, USA) located in a plastic holder with 
nose cone, providing air supplemented with 1.5% isoflurane (Attane, Minrad I, Buffalo, NY), 
and covered by a warming pad to maintain the body temperature. Ophtalmic ointment was 
used averting dryness of the eyes during the imaging process. Experiments were performed 
on a 4.7T small animal MRI system (Pharmascan 47/16 US; Bruker BioSpin MRI GmbH, 
Ettlingen, Germany) equipped with a linear polarized hydrogen whole-body mouse transmit-
receive radiofrequency coil.  
After a gradient-echo localizer scan in three spatial directions, the imaging protocol included 
an axial and sagittal T2-weighted, two-dimensional fast spin-echo sequences (2D-RARE) 
with time-to-echo (TE) = 33ms/  time-to-repetition (TR) = 2500 ms, number of averages 
(AVG) = 2, receiver bandwidth (BW) = 50000 Hz, echo train length =  8, echo spacing = 11.0  
ms, field of view (FoV) = 40 x 40 mm, slice thickness = 1.5 mm, matrix 256 x 256, voxel size 
= 0.156 mm x 0.156 mm x 1 mm were recorded to cover the leg in 20 slices. The duration of 
the scan was 1 min 20 sec.  
A further axial T2-weighted MR measurement was performed with a two-dimensional fast 
spin-echo sequence (2D-RARE) possessing the same geometry as applied for subsequent 
sequences measuring magnetization transfer. This scan was conducted with following 
parameters: TE = 33ms, TR = 6232 ms, AVG = 2, BW = 50000 Hz, echo train length = 8, 
echo spacing = 11.0 ms, FoV = 30 x 30 mm, slice thickness = 0.5 mm, matrix 128 x 128, 
voxel size = 0.234 mm x 0.234  mm x 0.5 mm  were recorded to cover the leg in 60 slices. 
The duration of the scan was 4 min 20 sec.  
Longitudinal and transverse relaxation times (T1 and T2 times) were determined by a 2D-
RARE sequence with 5 different echo times and 6 repetition times: TE = 11, 33, 55, 77 and 
99 ms, TR = 200, 400, 800, 1500, 3000 and 4500 ms, RARE factor = 2, AVG = 1, BW= 
50 000 Hz, FoV 30 x 30 mm, slices = 1, slice thickness = 1.0 mm, matrix size = 128 x 128, 
voxel size = 0.234 cm x 0.234 cm x 1.0mm. The acquisition time was 12 min 10 sec.  
Magnetization-transfer (MT) was measured with three-dimensional spoiled gradient-echo 
sequences (3D-FLASH). Sequence parameters were: TE = 4.7 ms, TR = 20.4 ms, AVG = 2, 
FA = 12°; BW = 50 000 Hz, sinc excitation pulse = 1 ms, FoV 30 x 30 mm x 30 mm (slice 
thickness = 30 mm), matrix size = 128 x 128 x 60, voxel size = 0.234 mm x 0.234 mm x 0.5 
mm, acquisition time = 5 min 35 sec. Measurements were performed with a MT pre-pulse of 
Gaussian pulse shape for each TR under systematic variation of the off-resonance frequency 
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covering 50 Hz – 37 500 Hz, FA = 800°, MT pulse length = 10.9 ms, MT pulse bandwidth = 
250 Hz, MT interpulse delay 0.01 ms, no dummy pulses. A reference scan for MTR 
quantification was acquired using the same sequence without any MT prepulse. Applying the 
same sequences used for imaging the hind limb on the lower abdomen on the urine-filled 
mouse bladder allowed to determine of the off-resonance frequencies saturating directly the 
water-bound protons due to the absence of macromolecules within the urine. 
Quantification of MR imaging parameter 
For all fitting procedures, non-linear least square fits to the signal intensities were performed 
based on the Levenberg-Marquardt-Algorithm (Matlab “lsqcurvefit”) in a pixel-by-pixel 
manner. 
For calculation of T1 time, the signal intensities of the RARE sequence were fitted to the 
equation 
                 
 
   
     (1) 
with TRi representing the applied repetition times. 
The T2 time was calculated from the RARE sequence by fitting the equation 
                     (2) 
to the signal intensities of the different echo times TEi with N meaning the noise. 
The MTR values (in %) were calculated from the MT sequences with and without MT 
prepulse in the following manner:                         
    
       
  
                            (3) 
with M0 meaning the signal intensity without MT prepulse and Msat the signal intensity with 
MT prepulse.  
Definition of a region-of-interest (ROI) 
Applying custom-written Matlab scripts (MathWorks, Natick, MA, USA) a region-of-interest 
(ROI) analysis was performed with manually drawn ROIs on anatomical images of the 
respective sequences. Three independent polygonal ROIs were drawn on each of three 
consecutive slices depicting the regenerating muscle areas. The image noise was 
determined in a ROI positioned outside the body in the upper left hand corner in the 
background of the image and corrected by squared subtraction according to Gudbjartsson 37.  
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Statistical evaluation and image post-processing 
For descriptive analysis, mean values and standard deviations of the regenerating 
musculature, the T1 and T2 times and MTR were calculated and numeric data are presented 
as mean ± standard deviation. Statistical evaluation of the acquired parameters between the 
study groups was performed by two-way analysis of variance (ANOVA) with Bonferroni 
correction using GraphPad Prism 5 software (GraphPad Software, Inc., La Jolla, CA, USA). 
Generally, a P-value of less than 0.05 was considered significant.  
Parametric maps of the regenerating TA were obtained by voxel-wise computation of the T1 
relaxation time, T2 relaxation time and the magnetization transfer ratio, followed by a twofold 
interpolation and Gaussian filtering (FWHM = 0.55 mm). 
3.4 Results 
There are notable morphological alterations over the time course of muscle regeneration as 
depicted by representative H&E stainings of serial cryostat sections of the TA (Fig. 1), but 
with overall subtle differences between the three study groups. Besides the muscle damage 
clearly visible in the images from POD 3-14, tissue specimens on POD 3 and POD 7, to a 
lesser extent on POD 14, are generally characterized by an infiltration of mononuclear cells 
being present in fairly large numbers in the injured musculature. The sections on POD 14 
display already elongated, rod-shaped cells and aligned regenerated muscle fibers, which 
are fully matured and densely aligned on POD 21 and by eventually reaching the structural 
characteristics of uninjured musculature the regeneration concluded in all study groups 
throughout the given time course of 3 weeks. A representative H&E stained tissue section of 
untreated, healthy TA is provided as control (suppl. Fig. 3). 
To further characterize the progress of myogenic differentiation supported by injected 
collagen, with and without transplanted human MPCs, versus PBS injection alone, 
immunohistochemical characterization of TA was conducted on POD 14 and on POD 21 by 
doublestaining either sarcomeric α-actinin or myosin heavy chain (hc) by a Cy3-labeled 
secondary antibody (red signal) and the nuclei of cells by DAPI (blue signal). Engrafted 
human MPCs pre-labeled with PKH-67 prior cell transplantation are directly discernable 
(green signal) and demonstrate the contribution of transplanted human MPCs to the overall 
regeneration process (suppl. Fig. 1, 2). Again, an equally immunohistochemically assessed 
tissue section of untreated, healthy TA is provided as control (suppl. Fig. 3). 
The immunofluorescent images of all study groups show an assembly of multinucleated 
myofibers  positive for sarcomeric α-actinin (suppl. Fig. 1) and positive for myosin heavy 
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chain (suppl. Fig. 2) at both assessed timepoints, and in the case of engrafted human 
MPCs, the green-fluorescent PKH-67 membrane dye applied for in vivo cell tracking of the 
MPCs colocalizes with the observed myofibers. Already on POD 14, the myofibers 
demonstrate a well-defined sarcomeric organization of both proteins being involved in 
muscle contractility, thus representing markers of myogenic differentiation. Moreover, there 
was no significant overlap between the DAPI-stained myonuclei and Cy3-stained contractile 
proteins within the myofibers. Nevertheless, the state of sarcomeric organization as well as 
the abundance of the assessed muscle proteins is indistinguishable within the three study 
groups.  
Muscle regeneration upon crush injury with subsequent transplantation of human MPCs 
versus injection of collagen respectively PBS alone was monitored by several MR 
parameters such as longitudinal and transversal relaxation times, T1 and T2, and the MTR 
(Fig. 2). Both, the T1 time and the T2 time increase as consequence of the crush injury, 
which is as relative mean T1 time for all groups approximately 120% of its initial relaxation 
time on POD 1, 3, and 7 (POD 1, 121.8±7.2%; POD 3, 122.3±6.8%; POD 7, 121.2±10.0%. 
Then, relative mean T1 time for all groups approaches respectively converges to baseline 
values on POD 14 and 21 (POD 14, 104.8±6.3%; POD 21 100.8±2.6%). There was no 
statistical significance comparing all the study groups. The relative mean T2 time prolongs 
for all three groups in average to 185 – 215% of its initial relaxation time on POD 1, 3, and 7 
(POD 1, 184.7±58.7%; POD 3, 213.5±62.8%; POD 7, 202.6±76.7% and regresses to 
baseline values on POD 14 and 21 (POD 14, 111.5±18.5%; POD 21, 101.9±4.4%). Again, 
there was no statistical significance between the study groups.  
While imaging the hind limb, same MT sequences were inevitably applied on the lower 
abdomen and hence the frequently urine-filled mouse bladder was imaged as well allowing 
consequently to measure the off-resonance frequencies saturating directly the water-bound 
protons, as the urine is devoid of any macromolecules. The off-resonance frequency 
avoiding direct saturation of water-bound protons could be determined with ≥2.500Hz (data 
not shown). In contrast to the relaxation times, the MTR inferred from measurements with an 
off-resonance frequency at 2500Hz shows a remarkable decline upon muscle injury and 
throughout the subsequent muscle regeneration, with a relative mean MTR for all groups 
decreasing gradually to 84.2±5.1% on POD1, to 73.1±6.0% on POD3 and to 67.7±13.0% on 
POD7 of its initial MTR value. Then again, the relative mean MTR increases gradually to the 
initially measured baseline values with 89.7±9.9% on POD14 and reaches 97.4±3.9% on 
POD21. The study groups did not differ significantly regarding their MTR values while 
regenerating the TA musculature.  
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Absolute mean values and standard deviation of the longitudinal and transversal relaxation 
times, T1 and T2 both in [ms], and the MTR in [%] for all study groups prior crush injury and 
on POD 1, 3, 7, 14, and 21 are given (Tab. 1). Furthermore, retrieved MR images depict the 
morphologic appearance of the TA musculature and representative parametric maps for T1 - 
and T2 relaxation and MTR retrieved for pre-surgical measurements and for all subsequent 
PODs demonstrate alterations regarding the assessed MR parameters in the course of 
muscle regeneration supported by the transplantation of human MPCs embedded in collagen 
(Fig. 3). 
3.5 Discussion 
In the wake of evolving stem cell therapies hopes are rising for a wide-ranging arsenal of 
therapeutic options to permanently reinvigorate damaged sphincter muscle tissue for SUI 5 
and thus, demanding a sensitive, non-invasive evaluation measure for monitoring therapeutic 
success that can be readily translated into human clinical trials. Here, T1- and T2- 
relaxometry as well as MT-MRI imaging were tested for evaluating myogenic differentiation in 
a murine TA muscle crush model facilitating muscle regeneration by MPCs injected in 
combination with collagen as scaffolding material and this investigation shows, that 
multimodal MRI allows for a detailed assessment of the regenerative process in musculature 
despite of the use of collagen embedding the injected MPCs. All three phases of muscle 
regeneration 21,38, as further supported by histological examination of muscle tissue, are 
mirrored by the retrieved MR parameters. 
The acute mechanical insult to the detrusor muscle, be it as consequence of vaginal delivery 
or prostatectomy, is causative for developing SUI and hence, in this study, a traumatic 
muscle crush injury was preferred for damaging the hind limb mimicking the actual onset of 
SUI over inflicting a nontraumatic damage by the intramuscular injection of myotoxins such 
as BaCl2 
25 or Notexin 27, especially as the myotoxin induced muscle injury models resemble 
rather conditions like muscular dystrophies 27. 
Initially, injured musculature enters within shortest time the inflammatory and degenerative 
phase (< POD 1), which is characterized by an initiation of the satellite cell proliferation and 
furthermore, by necrosis of ruptured myofibers leading to a strong inflammatory response, 
accompanied by an activation and infiltration of mononucleated cells such as neutrophils, 
macrophages 39. Having induced muscle injury by Notexin injection, also Mattila 27 describes 
the muscle necrosis as a process releasing intracellular, degraded macromolecules into the 
basal lamina cylinders and leading to a local accumulation and retention of fluids due to 
osmotic effects. Thus, this local inflammation, combined with the interstitial edema due to 
T1 -, T2 - relaxometry and magnetization transfer MRI permit non-invasive monitoring of stem cell supported 
skeletal muscle regeneration on a murine tibialis anterior crush injury model 
Discussion 
63 
vascular and myofiber leakage as a direct result of the crush injury 40, might consequently 
account for the instant increase of T1 and T2 values and to the decline of MTR values, which 
were also very prominent in other studies assessing muscle regeneration upon damage 25,27. 
Within the subsequent repair phase (POD 1-7), which is mainly characterized by the removal 
of cellular debris of necrotic muscle fibers by infiltrating macrophages, the MTR values 
gradually decrease further delineating the additional loss of fibrous protein matrix, whereas 
the T1 and T2 parameters remain at the high level as already observed on POD 1. Also a 
study on Duchenne muscular dystrophy emphasizes that both degenerating and 
regenerating muscle fibers with their elevated muscle water content due to interstitial edema 
account for increased T1 relaxation times 41,42. 
Eventually, the remodeling phase (POD 14-21) comprises the reorganization and fusion of 
newly formed myotubes with existing myofibers resulting in complete muscle recovery and 
therefore the relaxation times and the MTR parameters converge towards baseline values 
retrieved prior crush injury, which again is in line with previous studies assessing the 
myogenic differentiation of MPCs subcutaneously injected into a murine model by T1 – and 
T2-relaxometry 30 and by magnetization transfer MRI 29.  
For all study groups, the immunofluorescent images depict myofibers positive for sarcomeric 
α-actinin (suppl. Fig. 1) and positive for myosin heavy chain (suppl. Fig. 2) at both 
assessed timepoints, and in the case of transplanted human MPCs, the presence of the 
green-fluorescent PKH-67 membrane dye within those myofibers, initially applied for in vivo 
cell tracking of the human MPCs expanded in-vitro, confirmed the contribution of human 
MPCs to the myotube formation. In addition, these images clearly show the sarcomeric 
organization of the contractile proteins. Evidently, in the course of myogenic differentiation 
isolated human MPCs have evolved and fused with myofibrers as indicated by the green 
appearance of fully differentiated myofibers on POD 14 and 21 (suppl. Fig. 1).  
Nevertheless, the TA of young laboratory mice provides a highly regenerative biological 
background possibly obscuring the effects of the muscle regeneration driven by the injected 
human MPCs which might have been discernable otherwise in a background with restricted 
or even abrogated muscle regeneration 43,44. Moreover, there is an increasing amount of 
evidence showing that isolated MPCs lose their regenerative capacity in the course of in-vitro 
expansion after a few passages 9,44,45, probably aggravated by the fact that the MPC donors 
were patients in the age 50 – 60 years with a therefore age-related compromised 
regeneration potential 46. This might have led to an overall mitigated regeneration of the 
injured TA muscle mediated by transplanted MPC in this mouse model. Additionally, satellite 
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cells feature different properties depending on the origin of the muscle 47 which might have 
further influenced the observed regenerative effects of transplanted MPCs 48,49.  
In light of promising stem cell therapies helping in rebuilding urethral sphincter musculature, 
the rapid cell clearance of injected proliferating myoblasts, probably due to the adverse 
inflammatory environment created at site of injury, has to be averted by embedding MPCs 
into hydrogels of extracellular matrix (ECM) proteins such as collagen 21. Common ECM 
proteins, like collagen or fibrin have so far been extensively used in tissue engineering for 
providing the required scaffold for myoblast differentiation 38. The objective of this study was 
to further assess if non-invasive evaluation of muscle restoration is still feasible despite 
injecting fibrous ECM proteins as MPC carrier matrix and the direct comparison of MR 
parameters of all study groups proved that ECM application does not mask any of the 
myogenic restoration events amenable to MRI.  
Within the framework of this ethical approval obtained for the conducted animal experiments, 
it was unfortunately not possible to advance and refine this mouse model by radiation 
depletion of mouse satellite cells prior muscle crush injury and subsequent myoblast injection 
to fully observe the contribution of transplanted human MPCs to the overall regeneration 
process 43,44. This in fact represents a limitation of this study.  
Although there are additional studies required to eventually anchor non-invasive MR 
monitoring for the evaluation of myogenic differentiation in the context of stem cell therapies 
helping in rebuilding urethral sphincter musculature, these observations show that all stages 
of muscle restoration are amenable to multimodal MR imaging despite using ECM 
scaffolding materials. The application of fabricated protein scaffolds, allowing for a much 
higher degree of alignment and organization of the regenerating myofibers in combination 
with mouse models deficient in autologous satellite cells would be a logical and important 
next step of investigation. 
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3.7 Tables 
 
Tab. 1: Muscle regeneration upon muscle crush injury followed by the injection of collagen, 
with and without transplantation of human MPCs, versus PBS injection alone was monitored 
by several MR parameters such as longitudinal and transversal relaxation times, T1 and T2 
both in [ms], and the MTR in [%] for all study groups prior surgery and on POD 1, 3, 7, 14, 
21.  
POD Longitudinal relaxation T1 [ms] Transversal relaxation T2 [ms] MTR [%] 
 hMPC Collagen PBS hMPC Collagen PBS hMPC Collagen PBS 
  0 1681.2± 36.2 1722.1± 16.7 1663.0± 34.0 30.4± 1.3 30.4± 0.9 31.1±0.8 56.3±1.7 56.2± 1.4 56.3±1.3 
  1 2041.5±135.5 2132.8± 87.6 2018.6± 51.1 55.6±18.8 63.8±22.4 51.7±5.1 47.4±2.3 44.9± 3.8 50.1±1.6 
  3 2052.7±113.9 2090.8±134.7 2064.5±114.2 66.0±22.3 66.3±12.8 60.2±8.3 41.6±2.9 40.3± 3.6 40.3±5.1 
  7 2034.6±153.9 2039.1±273.2 2078.2±106.8 64.3±26.6 55.2±20.6 58.2±7.7 38.2±6.3 39.9±10.8 35.9±8.0 
14 1782.4±119.5 1706.5± 64.7 1763.1± 56.2 34.4± 6.9 33.4± 1.8 32.8±0.8 48.9±5.8 53.4± 1.8 54.0±4.6 
21 1704.9± 48.9 1678.5± 21.4 1692.6± 39.5 31.0± 1.5 30.9± 0.5 31.4±1.5 54.3±2.3 55.4± 1.9 56.4±0.8 
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3.8 Figures 
Fig. 1 
 
Representative images depicting H&E staining demonstrating the myogenic differentiation of 
the tibialis anterior musculature. Hematoxylin stained nuclei appear blue, whereas eosin 
stains proteins nonspecifically pink. The image shows cryosections of a tibialis anterior 
muscle specimens after muscle tissue after crush injury on POD 3, 7, 14, 21 with 
implantation of MPCs embedded in collagen, respectively with the injection of collagen and 
phosphate buffered saline alone. Scale bare, 100 µm.   
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Fig. 2: 
 
Muscle regeneration assessed by T1- and T2-relaxometry and MT-MRI, the latter with an off-
resonance frequency 2500 kHz, depicting the myogenic regeneration of the tibialis anterior 
muscle after crush injury for animals having received an injection of human MPCs embedded 
in collagen, respectively the injection of collagen and phosphate buffered saline alone. The 
diagrams show the pre-surgical measurement and POD 1, 3, 7, 14 and 21 of the longitudinal 
T1 - a) and transverse T2 relaxation b) and magnetization transfer c) retrieved for the 
regenerating musculature.   
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Fig. 3: 
 
Representative axial MR images depicting the morphologic appearance and the 
correspondent parametric maps of the T1 relaxation time, the T2 relaxation time and the 
MTR for pre-surgical measurement (Day 0) and POD 1, 3, 7, 14 and 21 after muscle crush 
injury on the tibialis anterior muscle and subsequent injection of MPCs embedded in collagen 
as scaffolding material.  
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Suppl. Fig. 1:  
 
Immunofluorescent images detecting sarcomeric α-actinin during the myogenic differentiation 
of the tibialis anterior musculature on POD 14 (upper panel) and on POD 21 (lower panel). 
Nuclei are stained by DAPI (blue signal) and α-actinin by cyanine-3 conjugated antibody (red 
signal), whereas only injected MPCs pre-labeled with PKH-67 prior cell transplantation are 
directly visible (green signal). The right image shows superimposed pictures obtained for 
each fluorophore. Scale bar, 25 μm.  
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Suppl. Fig. 2:  
 
Immunofluorescent images detecting myosin heavy chain during the myogenic differentiation 
of the tibialis anterior musculature on POD 14 (upper panel) and on POD 21 (lower panel). 
Nuclei are stained by DAPI (blue signal) and myosin heavy chain (myosin-hc) by cyanine-3 
conjugated antibody (red signal), whereas only injected MPCs pre-labeled with PKH-67 prior 
cell transplantation are directly visible (green signal). The right image shows superimposed 
pictures obtained for each fluorophore. Scale bar, 25 μm. 
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Suppl. Fig. 3:  
 
Immunofluorescent images detecting myosin heavy chain (upper panel) and sarcomeric α-
actinin (lower panel) in a healthy tibialis anterior musculature serving as control tissue. Nuclei 
are stained by DAPI (blue signal) and myosin heavy chain (myosin-hc) by cyanine-3 
conjugated antibody (red signal - upper panel) respectively α-actinin (red signal - lower 
panel). The right images show superimposed pictures obtained for each fluorophore. Scale 
bar, 25 μm. 
The image below depicts the morphology of skeletal muscle on a representative H&E stained 
cryosection of healthy tibialis anterior musculature. Hematoxylin stained nuclei appear blue, 
whereas eosin stains proteins nonspecifically pink. The image shows of a tibialis anterior 
muscle specimens. Scale bar, 100 μm. 
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